Skip to main content
Frontiers in Bioengineering and Biotechnology logoLink to Frontiers in Bioengineering and Biotechnology
. 2020 Jun 25;8:632. doi: 10.3389/fbioe.2020.00632

Continuous Cultivation as a Tool Toward the Rational Bioprocess Development With Pichia Pastoris Cell Factory

Miguel Angel Nieto-Taype 1, Xavier Garcia-Ortega 1, Joan Albiol 1, José Luis Montesinos-Seguí 1, Francisco Valero 1,*
PMCID: PMC7330098  PMID: 32671036

Abstract

The methylotrophic yeast Pichia pastoris (Komagataella phaffii) is currently considered one of the most promising hosts for recombinant protein production (RPP) and metabolites due to the availability of several tools to efficiently regulate the recombinant expression, its ability to perform eukaryotic post-translational modifications and to secrete the product in the extracellular media. The challenge of improving the bioprocess efficiency can be faced from two main approaches: the strain engineering, which includes enhancements in the recombinant expression regulation as well as overcoming potential cell capacity bottlenecks; and the bioprocess engineering, focused on the development of rational-based efficient operational strategies. Understanding the effect of strain and operational improvements in bioprocess efficiency requires to attain a robust knowledge about the metabolic and physiological changes triggered into the cells. For this purpose, a number of studies have revealed chemostat cultures to provide a robust tool for accurate, reliable, and reproducible bioprocess characterization. It should involve the determination of key specific rates, productivities, and yields for different C and N sources, as well as optimizing media formulation and operating conditions. Furthermore, studies along the different levels of systems biology are usually performed also in chemostat cultures. Transcriptomic, proteomic and metabolic flux analysis, using different techniques like differential target gene expression, protein description and 13C-based metabolic flux analysis, are widely described as valued examples in the literature. In this scenario, the main advantage of a continuous operation relies on the quality of the homogeneous samples obtained under steady-state conditions, where both the metabolic and physiological status of the cells remain unaltered in an all-encompassing picture of the cell environment. This contribution aims to provide the state of the art of the different approaches that allow the design of rational strain and bioprocess engineering improvements in Pichia pastoris toward optimizing bioprocesses based on the results obtained in chemostat cultures. Interestingly, continuous cultivation is also currently emerging as an alternative operational mode in industrial biotechnology for implementing continuous process operations.

Keywords: Pichia pastoris, continuous cultivation, steady-state omics, physiological characterization, rational bioprocess development, bioreaction kinetics, heterologous protein production, systems microbiology

Introduction

In recent years, recombinant protein production (RPP) technology has given rise to a multibillion-dollar market offering products for a wide range of industrial activities such as food, detergent, paper, chemical, cosmetic, and pharmaceutical production. For example, more than 400 RPP-based pharmaceutical products are currently available on the market (Sanchez-Garcia et al., 2016; Vieira Gomes et al., 2018). In parallel, and derived from the RPP technology, metabolic engineering has opened the door to metabolic flux modification and new heterologous reactions. This enable the manufacture of a wide range of products of interest including vitamins, amino acids, ethanol, antimicrobials, enzyme inhibitors, and organic acids. The overall economic impact of RPP and metabolite productions was estimated at around 143.5 billion US dollars in 2014, with upward forecasts until 2020 (Porro et al., 2011; Singh et al., 2017).

Various organisms ranging from bacterial hosts to transgenic animals have been proposed as efficient cell factories for bioprocesses with the mentioned applications. For example, for RPP, most of the products including pharmaceuticals and industrial enzymes are obtained with the main considered workhorses, namely: Escherichia coli, Saccharomyces cerevisiae or Chinese hamster ovary (CHO) cells (Sørensen, 2010; Maccani et al., 2014). However, the use of non-conventional yeasts, which combine eukaryotic ability for protein processing and major microbial advantages, have lately started to be considered as promising alternatives. In general, the new choices offer many advantages in terms of pathway requirements, desired product profile, and gross physiology over S. cerevisiae (Wagner and Alper, 2016). Such is the case with Schizosaccharomyces pombe, Hansenula polymorpha (syn. Ogataea polymorpha), Kluyveromyces lactis, Yarrowia lipolytica, or Komagataella phaffii (Pichia pastoris) (Çelik and Çalik, 2012; Baghban et al., 2019). Actually, at present Pichia pastoris (recently classified as Komagataella spp.) has arisen as an efficient and versatile cell factory for obtaining a wide spectrum of biotechnological products including recombinant proteins and metabolites of diverse origins (Gasser et al., 2013; Peña et al., 2018).

The key features that make P. pastoris an outstanding host for the above-mentioned uses include fast growth at high densities in defined media, the availability of advanced tools for genetic modification (e.g., CRISPR/Cas9 system) and the ability to perform post-translational modifications as well as to secrete the products extracellularly (Vogl and Glieder, 2013; Gasser and Mattanovich, 2018; Weninger et al., 2018). Furthermore, the increasing knowledge on P. pastoris metabolism gathered over the last decades, together with the high RPP potential of this yeast, have strongly increased the interest in using this microbial cell factory to obtain a variety of compounds. Thus, strengthening P. pastoris as one of the most suitable chassis for the biotechnological industry.

Promoters have proved to be key regulators for RPP processes. For P. pastoris, the methanol inducible alcohol oxidase promoter (PAOX1), a strong and tightly regulated promoter, was the first used obtaining efficient production rates of several proteins of interest (Cregg et al., 1993; Paulová et al., 2012; Ponte et al., 2016, 2018; Lee et al., 2017). Although PAOX1 affords outstanding RPP levels, using methanol has some relevant drawbacks, especially at production scale processes. These are mainly related with the increased costs and risk of storing and using methanol, as well as the increased oxygen demand and high heat production derived from methanol metabolization (Heyland et al., 2010; Prielhofer et al., 2013; Çalik et al., 2015). These shortcomings have given ground to dedicate important efforts to identify and to develop methanol-free alternatives, which can be classified in two categories: discovery of alternative efficient promoters for P. pastoris (PGAP, PPGK, PTHI11, PPYK, PSDH) (Periyasamy et al., 2013; Landes et al., 2016; Juturu and Wu, 2018; Massahi and Çalik, 2018; de Macedo Robert et al., 2019) and engineering or development of synthetic promoters (Ata et al., 2017; Wang et al., 2017; Prielhofer et al., 2018; Vogl et al., 2018b).

Nevertheless, not only is the promoter selection key in the strain engineering development to construct efficient cell factories, other relevant factors such as host strain background, gene engineering and dosage, protein processing helpers or secretion machinery also have a significant impact on the overall performance of the strain (Ahmad et al., 2014). Furthermore, it is crucial to combine the mentioned factors with an efficient bioprocess development from a bioprocess engineering approach (García-Ortega et al., 2019). For the latter, it should be essential to carry out a characterization producer clone used as a cell factory over different culture conditions to understand its performance and therefore, to design the rational based bioprocess strategies that allows to achieve the optimal performance for industrial bioprocesses (Yang and Zhang, 2018).

To obtain a proper characterization, cells should be kept under constant conditions in terms of both physico-chemical operating conditions as well as their metabolic state (Hoskisson and Hobbs, 2005). In this sense, continuous operation, which was first reported in 1920 (Cooney, 1979), is considered the most simple operational mode for this purpose. Continuous cultures are defined as a fermentation systems in which fresh medium is continuously added to the bioreactor and the components of the culture broth—cells and metabolites included—are continuously removed from the vessel (Fernandes et al., 2015); thereby forcing the cells to proliferate at a fixed rate and in a constant environment reaching the stationary state (Gramelsberger, 2018). The two main types of continuous cultures, chemostat, and turbidostat, are analogous and differ mainly in their cell growth control mechanism (Prielhofer et al., 2013; McGeachy et al., 2019). On one hand, chemostat is controlled through the continuous addition of culture medium in which a single nutrient is present at growth limiting conditions (Peebo and Neubauer, 2018). On the other hand, in turbidostat, the goal is to avoid nutrient limitation while growth is controlled by using an optical sensor which maintains a determined turbidity level by adding fresh medium through a feedback control loop. In this case, the resulting specific growth rate (μ) obtained is close to the maximum specific growth rate (μmax) of the microorganism used (Gresham and Dunham, 2014; Fernandes et al., 2015).

Additional alternatives such as “changestats” have been proposed as a novel tool where an environmental parameter is continuously changed in a single experiment. These approaches provide quick information about the response of cells in front of determined environmental conditions under what has been called steady state growth space analysis (GSA) (chemostat or turbidostat-based approaches) (Adamberg et al., 2015). Several variants have been described in the literature and have been listed and classified below according to the limitation or not of a nutrient and it is summarized in Figure 1.

Figure 1.

Figure 1

Overview of different continuous cultivation strategies. They are divided in two main groups: the first, corresponding to the “classical” approaches which work at steady state conditions; whereas for the other hand, changestats are variations of classical strategies proposed to obtain similar results but at dynamic conditions allowing faster results.

Nutrient-limited changestats:

  • – Accelerostats (A-stats) and deceleration-stats (De-stats), which are used to study the increase or decrease the specific growth rate, respectively (Nahku et al., 2010; Hoekema et al., 2014; Wagenen et al., 2015; Gerritzen et al., 2018).

  • – Dilution rate stats (D-stats), where an environmental parameter is continuously changed while the dilution rate is kept constant (Kasemets et al., 2003).

  • – Retentostats, where biomass is retained by means of internal or external filter devices. In prolonged retentostats, the energy derived from the consumed carbon source only allows to sustain the cellular maintenance but can no longer support biomass growth. This allows experiments to be performed at very low or near-zero specific growth rates (Herbert, 1961; Ercan et al., 2015a,b; Rebnegger et al., 2016).

Non-nutrient-limited changestats

  • – Auxo–accelerostats, allows to examine the effects of smooth environmental changes under nutrient-excess conditions (Nisamedtinov et al., 2008).

  • – Nutristats, where the dilution rate is a function of the set-point substrate concentration in the bioreactor (Curvers et al., 2002).

  • – Finally, as special case, adaptastats allow to operate under substrate-limiting conditions but, like turbidostats, work near μmax (Tomson et al., 2006).

Although changestats have been presented as promising alternatives to classical continuous cultures, it should be noted that in these systems cells grow in a quasi-steady state because the absence of a total stabilization phase prevents them from reaching steady state (Subramanian et al., 2017). This is the reason why chemostats continue to be the main choice for characterizing microorganisms under substrate-limiting conditions (Ziv et al., 2013). In fact, first reported in 1950 (Monod, 1950), chemostat cultures have proved the best operational choice for precise kinetic and metabolic characterization; also, they have provided the most accurate quantitative understanding at whole-cell level (Hoskisson and Hobbs, 2005). Thus, the empirical knowledge obtained from this characterization allows the determination of several parameters at different conditions, which therefore can be used to identify the optimal culture conditions toward the maximization of product related parameters such as production rates and yields. The relation between cultures and production parameters is detailed through different examples in the following sections. On the other hand, the application of systems biology approaches based on continuous cultures has enabled the development of new highly sensitive analysis tools capable of detecting slight changes at different regulation points, which can be deemed significant when integrating experimental results (Rebnegger et al., 2014).

The following sections describe the basis and uses of continuous cultivation with Pichia pastoris. Specifically, it has been focused on carbon-limited chemostat cultures, which according to the literature is the most used strategy for Pichia pastoris in continuous operation. The role of chemostat cultures has been reviewed as a powerful tool for the characterization of P. pastoris strains with a view to enabling the rational design of engineered cell factories and optimal operational strategies for maximal bioprocess efficiency.

Continuous Cultivation Provides an Excellent Tool for Systems Biology Research

Steady-State Omics, a Key Issue in the Renaissance of Research Into Continuous Cultures

The development of high-throughput molecular biology techniques in the post-genomic era has brought a renaissance of continuous cultures. At present, they are used not only in kinetic characterization and adaptive laboratory evolution (ALE) studies (Bull, 2010), but also as a powerful tool for gaining deeper insight into cell behavior thanks to the large amount of robust information they provide. In this sense, continuous cultivations have been used to understand cells response to internal traits such as those observed in engineered clones (using promoters engineering as an example) or to external stimuli such as operational strategies or environmental stress.

Transcriptomic, proteomic, metabolomics, and fluxomic data, can be jointly integrated into a systems biology approach (shown in Figure 2) in order to obtain an all-encompassing picture of a biological system used (Graf et al., 2009). A more detailed description is provided below in the next sections.

Figure 2.

Figure 2

Valuable information that gives continuous cultivation to systems biology for a deep understanding about cell physiology.

Transcriptional Studies

Transcriptional analysis is usually the first step in systems biology studies as it is also the first stage in the information flow from genomic data (Engstrom and Pfleger, 2017). Gene regulation can be examined by absolute or relative quantification of individual transcripts. Integrating this information enables further interpretation of data and reveals how the complex machinery behind a specific phenotype operates as a result of certain experimental conditions. The insight thus gained can be contrasted with knowledge derived from other structural levels of systems biology.

The contribution of transcriptional regulation to physiological outcomes is strongly dependent on the host employed. Thus, although 27% of all protein-coding genes in human cell lines are transcriptionally regulated (Vogel et al., 2010), the proportion amounts to 50% in E. coli and up to 70% in S. cerevisiae (Lu et al., 2007). These figures testify to the high significance of interpretations of transcriptional research in yeasts, where P. pastoris is taxonomically located.

Transcriptional data are typically acquired in either of two methodologies:

  • - One involves using specific primers for selected target genes either by real-time quantitative PCR (qPCR) (Landes et al., 2016) or droplet-digital PCR (ddPCR) analyses (Cámara et al., 2019). Both methods provide numerical results and hence quantitative data. Also, they are commonly used to examine the effects on the transcription regulation of certain genes of known sequence.

  • - However, other high-throughput technology methods such those using microarrays, based qualitative fluorescent detection, and/or RNA sequencing (RNAseq), which quantify the number of transcripts present in a sample by whole transcriptome sequencing, have arisen as helpful workhorses. In fact, these methods provide a robust overview of all transcripts (Baumann et al., 2010; Ata et al., 2018) and are thus especially useful when increased gene coverage is needed.

The selection of the method to be used in each case will be dictated by the specific objectives and information available about the studied system.

Continuous cultivation has proved useful for transcriptional analysis. Specifically, chemostats are frequently deemed the most suitable operational choice for this purpose, as seen with S. cerevisiae strains producing either recombinant proteins (Liu et al., 2013) or metabolites (Vos et al., 2015). As shown by several successful attempts described below, chemostat uses could be extended to P. pastoris, a similar cell factory related in the taxonomical group of yeasts.

Expression of heterologous proteins and metabolites in P. pastoris triggers many changes in cell physiology including stoichiometric drain of energy and cellular resources, or restrictions in the biochemical machinery responsible for bioproduct synthesis (Hesketh et al., 2013; Nocon et al., 2014). Identifying different points of regulation through transcriptional analysis can therefore allow useful information about cell performance to be obtained. Such information could be used to address new targets by strain engineering and to develop innovative, more efficient operational approaches by bioprocess engineering.

Puxbaum et al. (2015) provided a solid discussion about the potential limitations of RPP in P. pastoris; they found protein synthesis, folding, and secretion to be the main bottlenecks for the process. In this sense, Hesketh et al. (2013) directly observe stress arising during RPP by expressing under AOX1 promoter two lysozyme variants differing in degree of misfolding in chemostat cultures. The effect on unfolded protein response (UPR) was examined by using the RNAseq SOLiD platform. In addition, further RT-PCR analysis showed a constitutive splicing of HAC1 gene transcript across the different phases of RPP induction independent of the lysozyme misfolding level. The importance of this finding is based on the fact that Hac1p corresponds to a key transcription factor in the triggering of UPR response (Graf et al., 2008), and data obtained suggests that UPR is dependent on the transcript regulation of HAC1 rather than on the splicing process. As a result, the genes KAR2 and PDI1, which are further down the line in UPR, also exhibited high relative expression as revealed by RNAseq transcriptome analysis. Finally, a potential role of untranslated RNA molecules differentially regulated under different expressing conditions was suggested.

On the other hand, endoplasmic reticulum associated protein degradation (ERAD) is one other limiting factor for RPP (Dragosits et al., 2010; Adelantado et al., 2017). UPR and ERAD have been found to jointly control protein folding to a considerable extent and also, generally, heterologous protein synthesis, in P. pastoris (Delic et al., 2013; Zahrl et al., 2018). The relevance of both mechanisms as a response to RPP was confirmed by a microarray analysis intended to shed light on the transcriptional upregulation of these mechanisms in P. pastoris clones expressing a 2F5 Fab fragment relative to the wild type strain X-33 in chemostat cultures (Gasser et al., 2007).

Furthermore, it has been observed that transcriptional analysis provides useful information for characterizing native and engineered promoters. Thus, Landes et al. (2016) characterized the production of recombinant human serum albumin (HSA) by using an alternative promoter from the thiamine biosynthesis gene THI11, which is thiamine-repressible. An initial transcriptional assay on batch cultures using a specific transcriptional analysis with qPCR provided insight into the promoter performance under non-repressive conditions—absence of thiamine—and additional batch experiments allowed to define repression and de-repression effects of the thiamine concentration. Also, chemostat cultures were used to evaluate the performance of the same promoter under carbon-limited conditions at different specific growth rates in order to monitor production rates, and THI11 and HSA gene transcription. Whereas, the specific production rate (qHSA) improved with increasing specific growth rate (μ), gene transcription had no influence on the latter, indicating a constitutive nature of PTHI11.

In similar work intended to develop alternatives to the methanol-based expression system, Prielhofer et al. (2013) identified six novel promoters through microarray transcriptomics analysis under carbon non-limiting and limiting conditions (batch and chemostat cultivation, respectively). One of the promoters, PG1, corresponding to a high-affinity glucose transporter (GTH1), exhibited strong and tight regulation under carbon-limiting conditions. Also, further characterization of this promoter at variable specific growth rates in chemostat cultures revealed the optimal specific production rate at a dilution rate D = 0.07 h−1.

As it was observed previously, the useful information derived from the production kinetics of recombinant P. pastoris producer clones growing at controlled specific growth rates in chemostat cultures have also enabled further transcriptional characterization and expansion of existing knowledge about the impact of this key parameter for improvement of the cell factory. Thus, Rebnegger et al. (2014) performed a transcriptional analysis using microarrays on P. pastoris clone expressing HSA under GAP promoter in chemostat cultures to examine the transcriptional response at different μ values. They found qHSA and μ to be linearly related, and upregulation of ribosomal and translation-related genes in response to higher heterologous protein production. On the other hand, upregulation of UPR and secretory pathways at high μ levels suggested that, although high D rates resulted in no limitation in qHSA, they caused heterologous protein production-related stress. Furthermore, marked upregulation of transcriptional regulators involved in stress response as well as a carbon source and nitrogen responsive genes was observed at low μ levels, which suggest an adaptation to the carbon source limitation when the dilution rate was tuned. Finally, consistent with the widely reported Crabtree-negative effect on P. pastoris metabolism, mitochondrial transcripts were positively correlated to μ. It is worth mentioning that Crabtree effect corresponds to the respiro-fermentative phenotype widely reported for S. cerevisiae, however a similar phenomenon has been observed also in cancer cells (Warburg effect). In order to generate an alternative model for Warburg effect studies, Ata et al. (2018) convert Crabtree negative P. pastoris into a Crabtree positive. While determination of Crabtree phenotype was achieved using short- and long-term studies in chemostat cultures, RNASeq transcriptome and 13C central metabolism flux analysis were performed in batch cultures. The use of chemostats for further transcriptional and metabolic studies could be proposed to provide new insight of P. pastoris as better model than S. cerevisiae for Warburg effect studies.

One other interesting use of molecular biology in strain engineering is to integrate multiple target expression cassettes in the P. pastoris genome, which usually leads to substantially increased production. Previous reports suggest that gene dosage considerably influences specific productivity (Schwarzhans et al., 2016; Vogl et al., 2018a). Thus, Cámara et al. (2017) evaluated the effect in chemostat cultures growing at μ = 0.10 h−1 by using strains with multiple insertions of Rhizopus oryzae lipase (ROL) under AOX1 promoter (0, 1, 2, 4, 8, and 15 copies). As confirmed by ROL transcriptional levels in a ddPCR analysis, optimal specific extracellular lipase activity was obtained with the 2C clone. By contrast, transcriptomic analyses with microarrays revealed constraints with increasing ROL gene dosage on the transcriptional machinery (specifically, in the methanol expression regulator 1, Mxr1p) (Cámara et al., 2017). This information was used to design new clones carrying several copies of MXR1 and methanol-induced transcription factor (MIT1). As revealed by specific analysis with ddPCR, methanol uptake was found to have a positive effect on the transcriptional response; the effect, however, resulted in no increase in product activity (Cámara et al., 2019).

Not only strain engineering, but also new bioprocess strategies, have led to enhanced RPP. Therefore, better understanding the way cells adapt to different external conditions requires accurate physiological characterization (Baumann et al., 2008; Dragosits et al., 2010; Garcia-Ortega et al., 2016). Based on the positive effect of oxygen-limiting conditions on RPP (Baumann et al., 2008), the impact of these stress conditions was further examined by using transcriptional analysis with microarrays in samples obtained from chemostat cultures under normoxic, oxygen-limited and hypoxic conditions to study the expression of an antibody fragment (Fab) under the constitutive GAP promoter (Baumann et al., 2011). Supplementary proteomic and metabolic flux analyses, and lipid-profile analyses (lipidomics) support the findings obtained previously (Baumann et al., 2010; Adelantado et al., 2017). The ensuing information enabled thorough characterization of the oxygen-limiting effects observed in metabolism regulation, which included upregulation of genes associated to the glycolytic pathway, the oxidative branch of the pentose phosphate pathway (PPP), ergosterol and sphingolipid biosynthesis and UPR genes, while the tricarboxylic acid cycle (TCA) revealed transcriptional downregulation.

Osmotic stress has been reported to exert a beneficial effect on RPP. Thus, Dragosits et al. (2010) conducted a transcriptional analysis by using microarrays in combination with chemostat cultures and found increasing concentrations of KCl to result in upregulation of genes involved with UPR, ribosome biogenesis and translation, albeit only in the wild-type clone. Although a Fab-producing clone exhibited higher transcriptional levels than the wild-type strain, such levels were independent of the experimental conditions and no increase in product formation was observed at higher concentrations of KCl. This result suggests that upregulation of these genes as revealed by microarray analysis was previously triggered by a recombinant protein effect and that osmolarity induced no further increase.

Although most transcriptional analyses have been performed in chemostat cultures, some have been conducted in retentostats. Rebnegger et al. (2016) performed retentostat studies to outline the physiology and transcriptional response of P. pastoris under this operational condition at near-zero specific growth rates. Among the pool of genes that were differentially expressed in microarray hybridization for transcriptome analysis, upregulation in transcripts involved in alternative carbon source consumption (such as ethanol and methanol), global stress-related transcription factors and with nutrient responses reveal an adaptation of low substrate availability at near-zero growth rates. This finding reinforces the reduction observed in the maintenance coefficient (ms), in comparison to chemostat cultures growing at higher μ. Otherwise, protein synthesis in retentostat cultures exhibited insubstantial transcriptional regulation, so further research, for example with RP-expressing clones, to determine whether the alternative cultures could be useful with P. pastoris and to outperform S. cerevisiae translational capacity at low μ is proposed.

Proteomic Studies

According to the central dogma of molecular biology, the protein level falls at the last stage of the information flow (van Hove et al., 2016; Engstrom and Pfleger, 2017). This, however, is no reason to underestimate the importance of the information it provides. Proteomics emerged in the mid-1990s as a new approach to determine the proportion of functional proteins containing information translated into the transcriptome pool. Such information is useful to contrast and supplement data obtained at other levels in systems biology in order to support and strengthen the conclusions of other studies (Szopinska and Morsomme, 2010).

Proteomic analysis with various microorganisms has provided interesting results (Brejning et al., 2005; Rossignol et al., 2009; Arvas et al., 2011; Dragosits et al., 2011). The use of proteomics on P. pastoris has been widely used in different cultivation modes including chemostat, batch and fed-batch cultures (Baumann et al., 2010; Dragosits et al., 2010; Pfeffer et al., 2012; Vanz et al., 2012, 2014; Lin et al., 2013), though not so widely as in transcriptional analysis. This section focuses on applications involving continuous cultivation, specifically in chemostats.

The earliest example of proteome characterization was accomplished by Dragosits et al. (2009), who compared the effect of temperature changes on recombinant proteome. The greatest changes were observed at the highest and lowest temperature studied (20 and 30°C, respectively). In addition to increased specific productivity at 20°C, 2D-Gel electrophoresis followed by LC-ESI-QTOF tandem MS allowed the identification of 49 out of 150 spots that exhibited significant differences. Proteomic data revealed that some cellular processes were affected by low temperatures. On the one hand, energy metabolism, oxidative stress response, and protein folding protein levels occurred to a lesser extent; whereas, in amino acid metabolism and RNA/ribosomal biogenesis, an increase of protein levels might account for the positive effect on RPP at 20°C.

Dragosits et al. (2010) conducted a similar study to determine the effect of osmolarity on recombinant P. pastoris physiology. Thirty-seven out of the total spots detected, 300 for wild-type and 150 for recombinant clone, were successfully identified with significant changes. These results strengthen the findings of transcriptional analysis as regards energy metabolism and protein folding in both clones. On the other hand, as it was observed in transcriptional analysis, a positive effect on UPR response protein levels was observed at high osmolarity conditions, however it was only in control wild-type strain, whereas it was not the case for recombinant strain where no impact was exerted at different KCl concentrations. The author suggests that although osmolarity not exert a direct effect in producer clone, it could be used for preconditioning cells for RPP, and as outcome it can be considered on improved bioprocess and for generate novel routes for strain engineering.

Rußmayer et al. (2015) interpreted proteomic data at other levels of systems biology and demonstrated symbiosis by using multi-level analysis to expose the cellular processes involved in methanol metabolism. They found good positive correlation between transcriptomic and proteomic data, consistent with the strong transcriptional control over protein abundance in S. cerevisiae (Lu et al., 2007). Chemostat cultures on methanol–glycerol mixed feed revealed a positive correlation between protein production and transcripts from methanol metabolism, and also with peroxisome biogenesis. There was, however, no clear-cut relationship between the increased protein levels associated to the translation machinery and cytoskeleton organization, which were not reproduced at the transcriptional level.

The usefulness of proteomic analysis as a supplement to transcriptional and metabolic flux analysis can also be illustrated with the results under hypoxia conditions. Thus, Baumann et al. (2010) conducted an integrative multilevel study and found a strong positive correlation between transcriptional levels and protein data. This result provides support for the assumption that transcriptional regulation is stronger than post-transcriptional regulation in P. pastoris. In any case, proteomic data should never be considered irrelevant, particularly in those cases were transcript levels do not match protein expression and understanding the behavior of the cell factory is rather difficult as a result.

Metabolic Fluxes as Key Physiological Indicators

The physiological status of cells, which is directly reflected in their metabolic phenotypes, is a result of the interplay of various key cell processes and factors such as gene expression, protein production and kinetics, regulation and thermodynamic driving forces (metabolite concentrations). A metabolic phenotype is defined by the actual activities of the metabolic reactions in cells (viz., by reaction rates). Because they are rarely constant, reaction rates are usually determined under steady-state or pseudo-steady state conditions and commonly referred to as “metabolic fluxes,” which are thus key indicators of the physiological status of cells.

Determining metabolic fluxes remains difficult despite major technological advances in quantifying all components involved. In fact, it is not always possible to determine the concentrations of all relevant components; also, in vivo values for kinetic parameters are usually unavailable. A number of techniques have thus been developed to quantify metabolic fluxes collectively that are known as “metabolic flux analysis” (MFA) or, simply, “fluxomics.” Many of them have been applied to P. pastoris and the most salient are discussed below. Using those techniques for metabolic engineering improves existing knowledge of the physiological properties of biological systems, thus enabling the rational design of cell factories and efficient metabolic engineering cycles.

Metabolic Flux Analysis

As stated above, MFA is widely used for comprehensive analysis of the physiological effects of environmental changes or genetic engineering modifications. Metabolic fluxes (i.e., metabolic reaction rates in the steady state) provide an excellent operational picture of cell operation. A continuous culture provides a simple, convenient tool for maintaining a stable (in steady state) cell metabolism over long periods of time. Comparing metabolic flux distributions under different conditions allows a deeper understanding of the effects resulting from the genetic or environmental changes.

Although determining metabolic fluxes in continuous cultures has the advantage that cell inputs and outputs are stable, it is still a difficult task due to the large number of reactions taking place simultaneously in each cell. Because in steady state reaction rates are constant, it only requires considering the stoichiometry of the reactions to calculate metabolic fluxes. The mass balances for each metabolite involved in such reactions allow one to construct a linear metabolic model. Those metabolic models with a realistic degree of metabolic detail are known as Genome Scale Metabolic Models (GEMs). Using GEMs in combination with steady-state data should in theory allow one to calculate metabolic fluxes. Unfortunately, the intricate interconnections among metabolites, and the small number of flux measurements typically available (usually cell inputs and outputs only), prevent the accurate determination of most of the metabolic fluxes, which requires the combined use of mathematical models, optimization methods and/or experimental techniques such as 13C labeling (Ferrer and Albiol, 2014a,b).

Genome-scale metabolic models have become essential tools for MFA and rational-based strain engineering. These models are mathematically structured knowledge bases containing descriptions of all biochemical reactions, metabolites, and metabolic genes for a specific organism—a Biochemical, Genetic and Genomic (BiGG) knowledge base (King et al., 2016). GEMs can be used in a number of ways such as using their elementary modes or extreme pathways to predict phenotypic function, to improve understanding of the metabolism underlying structure, or using the well-known constraint-based modeling approach (Fong, 2014) to predict function, as examples.

Constructing so detailed BiGG knowledge bases is a continuously evolving process due to the still limited knowledge available on some cell details. The availability of the P. pastoris genome sequence allowed the development of the first metabolic reconstructions. Thus, the DSMZ70382 genome sequence, and the sequence from the GS115 strain, allowed the PpaMBEL1254 and iPP668 GEM, respectively, to be produced (Chung et al., 2010; Sohn et al., 2010). Although several improved versions of these P. pastoris GEMs have been reported (Ye et al., 2017; Tomàs-Gamisans et al., 2018), this is a continuously evolving field and new or upgraded versions of existing models are expected to appear in the near future.

The continuous cultivation methodology has been used to adjust and validate GEMs. Also, GEMs adapted to specific continuous culture conditions have been used with the latest algorithms and optimization techniques to determine metabolic fluxes under constrains derived from experimental data. This approach is highly useful for interpreting such data and also for designing effective metabolic engineering strategies. Its greatest advantage is that it can be used in any type of continuous culture experiment without the need for a special experimental technique such as 13C labeling.

The most common alternative to using an optimization technique for metabolic flux calculations involves obtaining supplementary experimental information. Adding a carbon-labeled carbon source to the input medium of a continuous culture is one common method for this purpose. A typical experiment involves establishing a continuous culture and, once it has reached steady state, replace the input culture medium with another one containing a 13C-labeled carbon source. The labeled substrate usually consists of a mixture of molecules labeled at different carbon positions in proportions that are selected according to the expected results. The information to be acquired can be either the distribution of the label once steady state is reached (Tomàs-Gamisans et al., 2019) or changes in the label during the transient labeling period (Heyland et al., 2011; Jordà et al., 2012, 2014b; Nocon et al., 2016). In either case, using this information jointly with steady-state input/output fluxes and a metabolic model allows one to calculate metabolic fluxes under specific conditions. Using GEMs in combination with 13C labeling requires solving a very large number of equations. It is thus common to use manually or automatically constructed “context-specific” core models (Tomàs-Gamisans et al., 2019) to facilitate calculations and handling of data. These methodologies have been used in combination with chemostat cultures to examine the impact of heterologous protein production and the effects of different environmental conditions on P. pastoris metabolism.

Specific growth rate is one of the basic variables influencing the distribution of metabolic fluxes, and the macromolecular and elemental composition of biomass. This specific rate is easy to regulate in continuous cultures. In P. pastoris, the influence of the specific growth rate has been studied by applying 13C labeling to chemostat cultures fed with various carbon sources (glycerol, methanol) or their mixtures (e.g., glycerol/methanol) (Jordà et al., 2014a; Tomàs-Gamisans et al., 2018). In general, the results were consistent with what is known as the “growth rate hypothesis” which states that increasing the specific growth rate increases the RNA and protein fractions of cells, thereby boosting protein synthesis and energy production at the expense of other fractions such as carbohydrates.

Biomass composition has also been found to depend on the particular carbon source. Thus, cells grown on methanol contain more protein than those grown on glycerol or glucose (Tomàs-Gamisans et al., 2018). This effect has also been seen with mixed glycerol/methanol or glucose/methanol feeds and can be ascribed to the methanol utilization pathway requiring an expanded metabolic machinery (Jordà et al., 2012, 2014a; Rußmayer et al., 2015). On the other hand, the amino acid composition of cells is virtually independent of their specific growth rate and only differs among carbon sources. Based on the foregoing, metabolic fluxes are calculated by using different biomass composition equations whichever the approach adopted (GEMs included). The environmental conditions also affect metabolic flux distribution. For example, altering the chemostat dilution rate or using a different carbon source alters the distribution of metabolic fluxes; as a result, specific consumption and production rates increase with increasing specific growth rate or by-products such as arabitol are formed (Jordà et al., 2014a; Tomàs-Gamisans et al., 2018). Interestingly, the amount of methanol directly dissimilated into CO2 is influenced not only by the specific growth (dilution) rate, but also by the methanol fraction in mixed feeds. Experiments using chemostat cultures have shown environmental factors such as oxygen-limited conditions or low temperatures to have a strong impact on MFA (Mattanovich et al., 2004; Dragosits et al., 2009; Baumann et al., 2010; Carnicer et al., 2012).

The other most extensively studied factor in P. pastoris continuous cultures in addition to the environmental conditions is the impact of heterologous protein production on MFA. For this purpose, the effects of different model proteins on metabolic flux distribution relative to their non-productive counterparts is usually compared under identical cultivation conditions. The type of heterologous protein produced and, especially, the amount produced, have proved considerably influential on metabolic flux distributions. Thus, increased heterologous protein production has been shown to shift metabolism toward increased energy generation, reduction equivalents (ATP, NADH, NADPH) and building block production (enhanced pentose phosphate pathway, PPP, or TCA cycles) while reducing biomass yield (Heyland et al., 2011; Jordà et al., 2012, 2014b; Nocon et al., 2016). Increased heterologous protein production has also been found to boost protein misfolding and, ultimately, trigger an unfolded protein response (UPR), thereby further draining resources and shifting metabolic fluxes (Graf et al., 2008). The effects of environmental factors and heterologous protein production on metabolic fluxes have fostered the development of in silico strategies to optimize metabolic engineering.

Bioprocess Characterization With Chemostat Cultures

Microbial Physiology Studies/Physiological Characterization of the Cell Factory

Increasing the efficiency of a bioprocess (i.e., increasing yields and productivities with high-quality proteins) requires a deep physiological understanding of the cell factory. For the topic discussed in this review, such knowledge is expected to eventually allow the rational development of feasible and competitive bioprocesses with shorter times to market. The overall approach is usually not straightforward due to the complexity of the different interactions occurring at many cell physiology levels. Thus, since the interactions between the cell factory performance and the bioprocess conditions define key parameters of interest (KPI) of the production, an empirical determination of those are required. In this sense, to obtain this kind of information accurately, chemostats are considered the most usual continuous cultivation applied (Hoskisson and Hobbs, 2005). As pointed out in the Introduction section, variations of the continuous operating mode can be alternatively implemented to determine nutrient and environmental effects on metabolism and physiology.

Chemostat cultures provide important advantages over other alternatives such as batch and fed-batch cultures. The advantages arise from the fact that operating under steady-state conditions provides highly robust and reliable data, thus allowing one to assess the effect of a specific parameter while keeping all others constant. Therefore, several cultivation conditions such as medium composition, carbon and nitrogen sources, dilution rates, and others can be investigated to optimize their use. Moreover, some additional strain features and bioreaction kinetics can be thoroughly determined using chemostat cultures. Currently, these parameters are considered of capital importance toward bioprocess optimization for the development of improved industrial processes.

Traditionally, shake-flask cultures have been used to find optimal conditions of physical parameters (pH, T) and concretely, batch or fed-batch cultures to determine oxygen requirements (DO, pO2) However, currently, continuous cultivations should be considered a preferred option to assess the effect of any culture conditions. The fact of working in steady state conditions in whichever cell population is considered homogeneous allows to obtain very accurate and reliable results. In contrast, dynamic processes such as batch of fed-batch cultures are expected to be less robust and present more deviations due to possible drifts in culture conditions. Furthermore, also parameter determination such as kinetic rates and yields is also considered to be more complex in dynamic processes.

Operating Conditions and Media Optimization

Bioprocess performance is influenced by some physical conditions of cultures including temperature (T), pH and dissolved oxygen (DO). The optimum conditions for production may differ from those for growth due to their effect on several factors including protein-specific characteristics, kinetics and sensitivity of products to proteolytic degradation.

The optimum growth temperature for P. pastoris bioprocesses is about 30°C, above 32°C protein expression is suppressed and cell growth rapidly decays (Çalik et al., 2015). However, some authors have suggested that operating at lower temperatures of up to 20°C may significantly improve production of heterologous proteins (Surribas et al., 2007). Decreased operating temperatures have a double but opposite effect. On one hand, the solubility of oxygen is increased and consequently the oxygen transfer rate (OTR) is improved. On the contrary, bioreaction rates such as intracellular reactions, proteolysis and cell growth diminish. Reduced proteolysis at low temperatures is the result of decreased protease activity rather than decreased proteases production (Sirén et al., 2006). Thus, some studies have focused mainly on this cultivation parameter. Data obtained in chemostat cultures on the production of an antibody Fab fragment, indicates that folding stress is generally decreased at lower cultivation temperatures, therefore enabling a higher efficiency for protein processing and secretion (Dragosits et al., 2009). The specific productivity was 3-fold higher at the lower temperature of 20°C, observing also a reduction on the flux through the TCA cycle, jointly with lower oxidative stress response and less presence of molecular chaperones.

Berrios et al. (2017) examined the effect of using co-substrates with methanol in the production of Rhyzopus oryzae lipase (Rol) by P. pastoris in continuous cultures growing at the same μ but at different temperature (22 or 30°C). Overall, the lower temperature led to lower specific productivities irrespective of the co-substrate used. Strikingly, lowering temperature produced an increase in biomass concentration.

As a conclusion of the studies focused on the T effect, the efficiency of a low cultivation temperature depends on the target protein, so this effect should be studied for each case.

The pH of P. pastoris cultures is commonly set at 5.0–6.5 (Looser et al., 2015). pH values above 8 diminish cell viability, and can reduce protein activity and stability (Çalik et al., 2015). However, the optimum pH for RPP depends on the properties of the target protein, especially stability related with the isoelectric point (pI). Since the selection of the optimal pH should also consider the effect on the proteases, a pH value of 5.5 is thus often used to minimize this deleterious effect. In addition, an inappropriate pH can cause some components of the medium to precipitate, which should be avoided by choosing a low value in the working range (Cos et al., 2006).

The dissolved oxygen tension in P. pastoris cultivation is typically maintained at 20–30% (air saturation) by having the bioreactor operate at a constant agitation rate and using air or oxygen-enriched air as the inlet gas in order to ensure fully aerobic conditions (especially in high-cell density cultures). Chemostat cultures have been used to examine the boosting effect of oxygen-limiting conditions on RPP. For example, Garcia-Ortega et al. (2017) compared different steady-states under oxygen-limiting conditions and found the optimum setting to provide a 3-fold increase in a specific production rate of the recombinant protein.

Using as simple and inexpensive media as possible is essential to reduce fermentation and protein purification costs for efficient RPP. The most common media for P. pastoris cultivation have been reviewed (Cos et al., 2006; Sreekrishna, 2010). However, some of them present important problems such as unbalanced composition, formation of precipitates, high ionic strength, etc.

One of the critical points in formulating cultivation media is the nitrogen source. In some cases, nitrogen is only supplied with the feed medium; in others, it is added when pH control is required. Nitrogen starvation produces an increase in protease activity which can be avoided by increasing the initial/inlet concentration of the nitrogen source. Protease inhibitors provide, in general, a more expensive alternative method to the use of protease-deficient strains in order to decrease the presence of proteolytic activity in culture broth (Shi et al., 2003; Sinha et al., 2005).

Cankorur-Cetinkaya et al. (2018) developed a new interesting medium formulation that provide an appropriate balance between cell growth and product formation in the synthesis of human lysozyme (HuLy) and the anti-idiotypic antibody 3H6 Fab in chemostat cultures of P. pastoris. Tyrosine supplementation increased productivity, but tryptophan addition had virtually no effect; also, phenylalanine addition increased HuLy expression but decreased 3H6 Fab expression.

The effect of biotin deficiency on the growth of P. pastoris producing a recombinant glycosylated avidin was studied in chemostat culture. Replacing biotin with aspartic acid and oleic acid, although they had a growth promoting effect, wash-out happened and avidin productivity decreased. The addition of small amounts of biotin provided stable chemostat cultures on methanol and enabled production of biotin-free avidin (Jungo et al., 2007b).

The composition of the cultivation medium also has a direct impact on osmolarity. Dragosits et al. (2010) examined the effect of osmolarity on cell physiology in wild-type and Fab fragment-producing strains of P. pastoris grown in carbon-limited chemostat cultures. Neither total protein nor specific Fab production was affected by osmolarity. However, proteins involved in energy metabolism and folding processes were affected by an increased osmolarity (especially with the wild-type strain). Also, a high osmolarity decreased biomass yield due to the increased energy maintenance requirements.

Carbon Sources

The main substrate for a recombinant production bioprocess is usually selected in terms of the promoter regulating the expression. With P. pastoris and constitutive promoters such as PGAP, glycerol and glucose are widely used as carbon sources because they result in high specific growth rates that are usually accompanied by adequate specific production rates (Garcia-Ortega et al., 2013). In PAOX1-driven systems, however, methanol is often the sole carbon source and inducer of protein expression (Barrigón et al., 2015).

Pichia strains exhibits a different phenotype regarding methanol assimilation. For MutS phenotype, cell growth is considerably slow relative to the standard strains, which are designated Mut+ strains. Cell growth and productivity in bioprocesses involving MutS strains can be improved by using mixed substrates in combination with a co-feeding strategy (Arnau et al., 2010, 2011). This increases the total concentration of the carbon source and the amount of energy supplied reducing process times, as well as reducing heat production and oxygen requirements relative to Mut+ bioprocesses. Glycerol and sorbitol are the most commonly used co-substrate jointly to methanol (Jungo et al., 2007a,c), although in repressed classical systems, glycerol may lead to lower specific production rates (Arnau et al., 2011; Potvin et al., 2012). New, unrepressed promoters allow glycerol and glucose to be used in combination with methanol to substantially increase RPP efficiency (García-Ortega et al., 2019).

The continuous strategy provides a powerful tool for assessing the potential impact of using co-substrates. The design of this system is usually based on the selection of a dilution rate (D) far enough from μmax, which should ensure that no accumulation of substrates apart from methanol is produced. Moreover, the methanol concentration used should be high enough to allow efficient induction of the target protein, but not so high as to inhibit cell growth or protein production.

D'Anjou and Daugulis (2001) used a substrate mixture of methanol and glycerol with a Mut+ strain for PAOX1-driven heterologous production of a sea raven antifreeze protein. The specific product formation rate (qP) and product-based volumetric productivity (QV) increased throughout the range of dilution rates used (0.01–0.10 h−1). Similarly, Boze et al. (2001) studied the production of recombinant porcine follicle-stimulating hormone (rFSH) with mixed substrates of sorbitol and methanol. Neither protein production nor QV or qP increased relative to the use of methanol as sole carbon source at the same dilution rate (0.01 h−1). However, the substrate concentration ratio was not optimized in either study.

Jungo et al. (2007a) studied the influence of the methanol fraction in the feed medium on recombinant avidin productivity and specific alcohol oxidase activity by using a glycerol–methanol mixed substrate to grow a P. pastoris Mut+ strain expressing recombinant avidin at a constant dilution rate D = 0.06 h−1. With methanol fractions higher than 0.6 C-mol C-mol−1, qP was like cultures performed with methanol as sole carbon source.

Canales et al. (2015) used the production of Rhizopus oryzae lipase (Rol) as a model system to investigate the application of methanol-glycerol feeding mixtures in the P. pastoris Mut+ producer clone. Cultures were grown in a simple chemostat system and response surface methodology was used to evaluate the effects of D and the methanol/glycerol ratio in the feed as experimental variables. The optimum conditions provided qP values similar to, and QV values higher than those of processes using methanol alone as substrate. Furthermore, Berrios et al. (2017) compared the effect of glycerol and sorbitol as co-substrates for methanol in continuous cultures growing at the same rate. Higher QV, but lower qP and volumetric methanol consumption rates were observed using glycerol as a co-substrate at either 22 or 30°C.

Paulová et al. (2012) used a mixture of glucose and methanol in continuous cultures of a Mut+ P. pastoris strain to obtain recombinant trypsinogen. No repressive effect of glucose on methanol was observed under conditions far enough from μmax. The product was synthesized throughout the D range, with enhanced productivity at intermediate D values that was significantly higher than with methanol alone in the feed.

Niu et al. (2013) used a co-feeding strategy based on a methanol–sorbitol mixture with the aim of reducing the high oxygen demand at large-scale operation. Thus, they used transient continuous cultures of a Mut+/PAOX1-lacZ strain at a fixed dilution rate. While a linear change of methanol fraction was conducted, cell growth and metabolism, including O2 consumption, CO2 and heat production were analyzed. Based on the results, decreasing the methanol fraction in the feeding medium reduced the specific oxygen uptake rate and maintained maximal ß-galactosidase qP. Production was optimal with methanol fractions over the range of 0.45–0.75 C-mol C-mol−1.

Although glucose and sorbitol have also been tested as co-substrates jointly with methanol for Mut+ phenotype, glycerol is the most selected co-substrate to improve the productivity and to reduce the specific oxygen uptake rate and heat generation in continuous cultures in comparison with the sole use of methanol as a substrate. However, the methanol:glycerol ratio and the operating dilution rate must be empirically optimized for each target protein.

Bioreaction Kinetics

The physiological characterization of the producer strains, production rates and yields included, is currently considered critical for bioprocess development. Environmental factors affect cell factories in terms such as rearrangement of central carbon, amino acid metabolism and other basic functions, all of which have a direct impact on cell growth, folding stress, and vesicular transport, and also potential implications in protein secretion and other phenomena influencing production rates and yields (Baumann et al., 2010; Zahrl et al., 2017).

Continuous cultivation is the most frequently used operational mode to obtain accurate physiological data for reliable characterization. By contrast, fed-batch cultures are usually deemed less robust, and more laborious and time-consuming (García-Ortega et al., 2019). Also, stress conditions associated to high-cell density cultures can eventually occur and render them unsuitable for accurate physiological studies.

On the other hand, the use of dynamic process conditions for fast physiological strain characterization in order to reduce experimental time associated to conventional fed-batch and/or continuous cultivation has been reviewed (Spadiut et al., 2013). Moreover, the use of transient continuous cultures in order to reduce the time-consuming steady-state experiments was also implemented in the quantitative study of using mixed feeds (Jungo et al., 2007a).

Table 1 summarizes the continuous cultures used so far to characterize the bioreaction kinetics involved in some RPP processes with P. pastoris. The table shows the target protein, strain, promoter, substrate, operating strategy, and product formation kinetics. As can be seen, chemostat cultivation was the norm, but alternative strategies based on S-stats (nutriostats) (Curvers et al., 2002) or DO-stats were also used (Yamawaki et al., 2007).

Table 1.

Summary of continuous cultures used as a tool toward the rational based bioprocess development with P. pastoris cell factory.

Protein expressed Strain Promoter Substrate Continuous strategy Production kinetics Optimization approach References
Fab fragment (anti-HIV antibody 2F5) X-33 GAP Glucose Chemostat Growth-coupled
μ-saturated
Optimized feeding from continuous data Maurer et al., 2006
Fab fragment (anti-HIV antibody 3H6) X-33 GAP Glucose Chemostat Growth-coupled
μ-saturated
Optimized feeding from continuous data Buchetics et al., 2011
Fab fragment (anti-HIV antibody 2F5) X-33 GAP Glucose Chemostat Growth-coupled Optimal D at continuous mode Garcia-Ortega et al., 2016
hGM-CSF (human) GS115 Mut+ GAP Glucose Chemostat Linear Fed-batch designed from continuous data Khasa et al., 2007
phytase X-33 GAP Glucose Chemostat Linear Fed-batch designed from continuous data Tang et al., 2010
srAFP GS115 MutS AOX Glycerol/methanol Chemostat Growth-coupled Fed-batch designed from continuous data D'Anjou and Daugulis, 2001
°scFv GS115 Mut+ AOX Methanol DO-stat
S-stat
Bell shaped
μ-saturated
Trade-off between fed-batch and continuous Yamawaki et al., 2007
hCTRB GS115 Mut+ AOX Methanol Nutriostat Linear Optimal D at continuous mode Curvers et al., 2002
rHV2 GS115 Mut+ AOX Methanol Chemostat Bell shaped Fed-batch designed from continuous data Zhou and Zhang, 2002
Porcine trypsinogen X-33 AOX Glucose/methanol Chemostat Bell shaped Optimal D at continuous mode Paulová et al., 2012
Avidin GS115 Mut+ AOX Methanol/glycerol/ sorbitol Chemostat Linear Fed-batch designed from continuous data Jungo et al., 2006, 2007a,c
CalB X-33 PGK Glycerol Chemostat Linear Trade-off between fed-batch and continuous de Macedo Robert et al., 2019
Serum albumin (human) X-33 THI11 Glucose Chemostat Growth-coupled Optimized feeding from continuous data Landes et al., 2016

The most common types of kinetics reported for cell growth (μ), substrate uptake (qS), and product formation (qP) are Monod for cell growth, Pirt's as a maintenance energy model and Luedeking–Piret as linear μ-dependence for substrate uptake and product formation, respectively. However, saturation patterns, non-monotonic behaviors or bell-shaped types have also been observed, especially in substrate-inhibited systems for cell growth and non-constitutive RPP (Barrigón et al., 2015).

The kinetics of oxygen uptake, carbon dioxide production, and substrate uptake can usually be fitted to a linear model thanks to the rather linear relationship between specific rates and the specific growth rate. These have been widely discussed in several studies on chemostat cultures of P. pastoris (Maurer et al., 2006; Rebnegger et al., 2014; Looser et al., 2015; Garcia-Ortega et al., 2016).

Because production kinetics is influenced by a number of physiological interactions, the overall balance of the different steps from gene transcription to product secretion is usually considered instead. As discussed by some authors, the correlation between qP and μ is specific for each case, so it must be determined experimentally for each individual strain and protein under fixed operating conditions (Looser et al., 2015). The data of Table 1 confirm that production kinetics is not only influenced by the promoter used with each strain but also, often, protein-specific. For this reason, the most widely used expression systems (viz., that driven by methanol-inducible PAOX1 and the constitutive glycolytic PGAP) usually exhibit different production kinetics. Thus, the PAOX1-driven expression system often exhibits non-monotonic kinetics, possibly as a consequence of the metabolic burden resulting from methanol uptake and/or protein processing, and from secreting limitations due to outstanding expression levels (García-Ortega et al., 2019). In this situation, maximizing bioprocess efficiency entails using intermediate μ values far from μmax. On the other hand, a growth-coupled increasing correlation between μ and qP has been observed in constitutive expression systems relying on glycolytic promoters such as GAP or PGK (Rebnegger et al., 2014; Garcia-Ortega et al., 2016; de Macedo Robert et al., 2019), and also with the thiamine sensitive THI11 promoter (Landes et al., 2016), qP peaking at higher μ values closer to μmax.

For most proteins, however, qP is related to μ by a growth-coupled production model (D'Anjou and Daugulis, 2001; Rebnegger et al., 2014; Garcia-Ortega et al., 2016) and even, possibly, by a Luedeking–Piret or μ-linear model (Curvers et al., 2002; Jungo et al., 2006; Khasa et al., 2007; Tang et al., 2010). Other, partially growth-dependent, exhibit a μ-saturated production pattern (Maurer et al., 2006; Buchetics et al., 2011) or fit a bell-shaped model (Yamawaki et al., 2007). For example, Yamawaki et al. (2007) found qP for scFv to exhibit either a saturation behavior on μ or bell-shaped kinetics depending on the operational mode used (continuous or fed-batch cultivation). For other proteins, studies performed in chemostat (Paulová et al., 2012) or fed-batch cultures (Zhou and Zhang, 2002; Zhang et al., 2005) have shown them to fit μ non-monotonically increasing or bell-shaped models.

In Table 2 a comparison of qP and YP/X according to the μ reached in continuous and fed-batch bioprocesses is presented. This table includes results obtained with different target proteins, promoters, gene dosage, substrates, and feeding strategies. In continuous mode, YP/X normally decreases when μ increases, but in contrast qP increases along with μ, except in the production of hSA where YP/X increases when μ increases, which is probably associated with the high gene dosage (6 copies) (Landes et al., 2016). In general, this linear behavior between qP and μ is related with the commonly observed μ-dependence in P. pastoris bioprocesses, which indicates that the product formation is growth-dependent.

Table 2.

Comparison of specific production rates (qP), product yields (YP/X), and volumetric productivities (Qv) between continuous and fed-batch operating modes with different proteins produced, promoters/gene dosage, substrates, specific growth rates (μ), and feeding strategies used.

Continuous Fed-batch References
Protein Promoter/gene dosage Substrate μh−1 qPAU/(gX·h) YP/XAU/gX QvAU/(L·h) μh−1 qPAU/(gX·h) YP/XAU/gX QvAU/(L·h)
Crl1 PGAP
Sc
Glucose 0.056
0.081
0.136
78.2
89.1
126
1,400
1,093
930
1,924
2,410
3,108
0.048
0.087
0.133
77
149
292
1,610
1,700
2,190
2,195
3,246
10,442
Nieto-Taype et al., 2020
Crl1 PAOX
sc
MetOH 0.020
0.050
0.079
118
271
310
6,017
5,398
3,939
2,291
5,564
6,874
0.028
0.053
0.084
364
588
326
13,155
11,299
3,911
2,291
5,564
6,874
Garrigós-Martínez et al., 2019
CalB PPGK
Sc
Glucose 0.050
0.090
0.160
20.4
38.4
59.1
449
423
377
449
864
1,331
0.060
0.110
0.140
19.4
47.5
52.3
323
423
377
402
796
868
de Macedo Robert et al., 2019
Phytase PGAP Glucose 0.050
0.150
0.300
480
820
1,420
9,600
5,500
4,700
nd
nd
nd
DFP 0.118
DFP 0.125
DFP 0.125
567
586
628
4,800
4,680
5,020
20,900
17,400
18,700
Tang et al., 2010
Protein Promoter/gene dosage Substrate μh−1 qPμg/(gX·h) YP/Xmg/gX Qvmg/(L·h) μh−1 qPμg/(gX·h) YP/Xmg/gX Qvmg/(L·h) References
Human FAB 2F5 PGAP
sc
Glucose 0.050
0.100
0.150
17.2
32.4
45.7
0.33
0.32
0.30
0.34
0.70
1.04
0.050
0.101
0.146
7.7
25.7
35.2
0.15
0.25
0.24
0.24
0.64
0.73
Garcia-Ortega et al., 2013, 2016
Human FAB 2F5 PGAP
sc
Glucose 0.060
0.100
0.150
25.1
34.0
41.4
0.42
0.34
0.28
0.62
0.94
1.14
CFR

OFR
10.0

30.0
0.48

0.48
0.39

0.67
Maurer et al., 2006
Human FAB 3H6
CLB2
PGAP
sc
Glucose 0.190
0.050
0.100
0.150
45.6
48.1
60.5
66.1
0.24
0.96
0.60
0.44
1.38
1.32
1.66
1.82

OFR

10

0.45

nd

Buchetics et al., 2011
rHV2 PAOX MetOH
0.4 g/L
0.017 nd nd nd 0.01 0.03 3.0 nd
MetOH
0.6 g/L
0.020 nd nd nd 0.02 0.20 9.8 nd Zhou and Zhang, 2002
MetOH
1.5 g/L
0.040 nd nd nd 0.04 0.08 2.0 nd
CLC 0.018 0.17 9.6 14
hSA PTHI11
6 copies
Glucose 0.050
0.075
0.100
0.125
0.150
0.003
0.017
0.050
0.119
0.180
0.06
0.22
0.50
0.95
1.20
0.05
0.30
1.00
2.38
3.60

0.150

0.023

0.88

2.60

Landes et al., 2016
Avidin PAOX *MS-MS
(% Methanol C-mol)
6
25
43
65
100
0.03
0.03
0.03
0.03
0.03
0.003
0.013
0.016
0.016
0.016
0.11
0.42
0.54
0.52
0.54
0.03
0.13
0.16
0.13
0.12

0.027

0.049

1.78

3.24

Jungo et al., 2007c

SC: Single Copy; nd: not determined; All the fed-batch cultures were carried out by implementing open-loop feeding strategies except: DFP, Different Feeding Profile; CFR, Constant Feed Rate; OFR, Optimized Feed Rate; CLC, Closed Loop Control;

*

Mixed-substrates Methanol-Sorbitol. Some values have been estimated from the values indicated in the references or directly from the figures. For rHV2, hSA, and avidin, qP is expressed as mg/(gx·h).

When the data obtained in both, continuous and fed-batch mode are compared, the analysis is often difficult because not all the examples have been studied for coincident μ's. However, the qP behavior is quite similar for the two operating modes, only for the case of rHV2 and Crl1 production regulated by PAOX1, which qP presents a maximum at intermediate μ for the fed-batch cultivation not following a product formation growth-dependent pattern. On the other hand, there is not a common trend in reference to YP/X behavior in front of μ, observing different positive and negative linear relationships, bell-shaped and saturation patterns.

In terms of absolute values, only in the case of Fab 3H6 and hSA production, the specific production rate (qP) and the YP/X values were always higher in continuous mode at similar μ comparing to those obtained in fed-batch cultivation.

Additionally, since productivities could be one of the main performance criteria from an industrial point of view, volumetric productivity (QV) has been also included in Table 2. Nevertheless, the comparison could not be made in a suitable way because the biomass concentration and the reactor volume may not be equivalent in the two operating modes. Moreover, for a proper comparison it had to be also considered a time window of several weeks in order to take into account the unproductive time between consecutive fed-batches. For instance, taking these factors into consideration, overall CalB production was reported as 5.8 times greater in continuous culture (de Macedo Robert et al., 2019).

The results of this experimental approach, which is mostly performed in chemostat cultures, provide a wealth of knowledge to tailor rational strategies with a view to optimizing bioprocess operating conditions for increased production rates and yields. Although production patterns are expected to be similar when using the same expression system to produce different target proteins, the outcome usually depends on both. Therefore, optimal bioprocess development requires using similar experiments not only to maximize production rates, but also to identify the most suitable conditions for testing other strains with industrial potential. Chemostats therefore provide an effective platform for easily characterizing production strains and elucidating production kinetics by the obtention of accurate and robust data.

Bioprocess Optimization and Process Development

Most of the bioprocesses currently used for recombinant protein or metabolite production are performed in the fed-batch mode on the grounds of the high cell concentrations it affords, and the increased amounts of product obtained as a result. Therefore, using the data obtained from chemostats with fed-batch cultures requires that the latter operate in a pseudo-stationary state or balanced growth in order to maintain the overall μ value rather constant during the process. This can be accomplished by using a fed-batch strategy based on pre-programed exponential feeding derived from mass balances. Under these conditions, if μ is kept constant and the biomass-to-substrate yield rather constant throughout the cultivation period, the substrate can be assumed to reach a pseudo-stationary state.

Table 1 summarizes works with continuous cultures as a tool for further rational process development based on the physiological characterization of the producer strains. As can be seen, three main approaches have been used for optimal RPP. One involves identifying the optimum D conditions under continuous operation for key parameters of interest (KPIs) including productivities (Curvers et al., 2002; Paulová et al., 2012). Another uses a trade-off between fed-batch and continuous operation for yields or productivities depending on the particular design or performance criteria (Yamawaki et al., 2007). The third is a sequential approach to bioprocess design (i.e., fed-batch operation is designed and implemented on the basis of production kinetics or productivity data obtained under continuous operation) (Zhou and Zhang, 2002; Jungo et al., 2007a,c; Khasa et al., 2007; Tang et al., 2010).

Garcia-Ortega et al. (2016) characterized the recombinant production of Fab fragment 2F5 driven by the constitutive promoter PGAP in chemostat cultures. A positive effect of high μ levels on productivity was observed, which confirmed that production was growth-coupled.

de Macedo Robert et al. (2019) compared Candida antarctica lipase (CalB) production with the constitutive promoter PGK in continuous and fed-batch cultures. They found volumetric and specific productivity to peak at the highest μ levels, which indicated a direct correlation between growth and production.

Production kinetic profiles for other proteins have also been obtained in other continuous cultures that were used as references to develop optimal feeding strategies adjusted to cell factory performance. The result was a marked increase in production in terms of volumetric productivity and product titer for some Fab fragments (Maurer et al., 2006; Buchetics et al., 2011) and human serum albumin (Landes et al., 2016).

D'Anjou and Daugulis (2001) used glycerol–methanol mixtures as co-substrates for continuous cultures to obtain sea raven antifreeze protein (srAFP). They elucidated the relationship of μ to the yield on methanol, qS on methanol and qP and then used data collected under continuous operation to predict cell growth and RPP, as well as to develop an exponential feeding strategy for fed-batch cultures with the same two carbon sources. The outcome was increased product yield and productivity relative to a heuristic approach.

Is Continuous Cultivation a Real Alternative for its Use in Industrial Pichia Pastoris Processes?

The Transition of Industrial Biotechnology From Batch/Fed-Batch Mode to Continuous Manufacturing

The main current trend in bioprocess optimization is to move away from standard, fixed protocols toward concepts enabling the operator to adapt particular recommendations to any specific clones, strains or bioreactors (Looser et al., 2015). This requires combining effective strains and bioprocess engineering approaches for optimal results, and also avoiding complex media to reduce costs and facilitate downstream processes with a view to increasing economic viability of the bioprocess (Sreekrishna, 2010; Potvin et al., 2012). In this sense, due to the relevant advantages of the continuous manufacturing, as once pioneered in the oil and chemical industry, many industrial bioprocesses are expected to eventually evolve from batch or fed-batch to continuous processes (Croughan et al., 2015).

Currently, continuous biomanufacturing processes based on the application of continuous fermentation are being carried out in different industries including ethanol, lactic acid, and numerous biopharmaceutical productions. Mears et al. (2017) discussed some of these examples performed with continuous microbial systems at industrial scale to evaluate the expected wide implementation in biopharmaceutical biomanufacturing processes. Actually, the US FDA has encouraged the development of continuous processing for biopharmaceuticals manufacturing (Croughan et al., 2015). In this sense, it is worth mentioning that Novo Nordisk implemented the continuous insulin production with the yeast S. cerevisiae since the 1990's (Peebo and Neubauer, 2018). And currently, several commercial biopharmaceuticals such as monoclonal antibodies or therapeutic proteins are recombinantly produced in continuous perfusion cultures of mammalian cell lines (Mears et al., 2017).

Industrially, switching from batch to continuous operation can have several advantages such as reduced processing costs, increased productivity, and product quality, and the ability to integrate upstream and downstream in a continuous manner (Cankorur-Cetinkaya et al., 2018). However, bottlenecks in industrial bioprocesses are generally product-specific and must be identified on a case-by-case basis with provision for economic constraints (Yang and Zhang, 2018).

Continuous cultures growing under steady-state conditions are, in theory, more effective in this mode than are batch or fed-batch cultures. In this mode, which is usually performed at a constant μ, most of the factors involved in the RPP as well as a large fraction of the transcriptome, proteome and fluxome can be considered constant, since it has been reported that they are coordinated by μ (Peebo and Neubauer, 2018). Therefore, continuous cultivations where μ can be easily fixed, simplifies significantly the interpretation and control of the bioprocess. In this way, bioprocesses should be easier to characterize, understand, control and maintain under optimal conditions over long periods. Furthermore, the lag and dead times, intrinsically associated to batch and fed-batch operation, result in considerably diminished productivity. Hence, continuous biomanufacturing processes allow reducing running costs, minimizing equipment size, integrating upstream and downstream steps, increasing product quality, ensuring constant product recovery, and making processes scalable are additional advantages of continuous cultures over batch and fed-batch cultures (Peebo and Neubauer, 2018).

However, continuous cultivation also has some drawbacks arising from the need to ensure long-term stability and sterility in the cultures, and to shorten average long development times (Croughan et al., 2015). Specifically, the genetic instability of recombinant strains may limit the length of RPP bioprocesses; especially for with P. pastoris strains. Clone stability can be confirmed by testing productivity over a large number of generations under steady states (about 20–30 residence times) in chemostat cultures growing under a steady state. Alternatively, it can also be assured with periodic changes in dilution rate or the aeration conditions (Cankorur-Cetinkaya et al., 2018). Additionally, and concretely for multi-copy strains, the gene dosage conservation in continuous cultures maintained over long periods is important to be checked.

Challenges to Be Addressed in Pichia Pastoris Continuous Cultivations

An important requirement with continuous bioprocesses is to develop effective alternative promoters to replace the classical PAOX1, which is widely used efficiently in fed-batch processes but is not recommended for continuous RPP. In fact, identifying strong and constitutively expressed promoters, and testing them in continuous cultures currently still remains a major goal (Cankorur-Cetinkaya et al., 2018). Obviously, efficiently exploiting the potential advantages of continuous cultivation requires integrating upstream and downstream bioprocess flows. Thus, the implementation of new approaches is a challenge for biotechnology companies in order to reach short process development times jointly with minimal risks in the context of possible hard quality/regulatory requirements (Rathore et al., 2015). At this point a question arises: is continuous cultivation a real alternative to fed-batch cultures for its use in industrial biotechnology based on the Pichia pastoris cell factory?

Gasser and Mattanovich (2018) reported some interesting guidelines to transform this yeast from an efficient cell factory to a useful chassis for the production of recombinant proteins and biochemicals as a real alternative to Saccharomyces cerevisiae. Furthermore, Moser et al. (2017) investigated the impact of long-term carbon source adaptation toward improved cell growth in RPP processes with P. pastoris in the context of Adaptive Laboratory Evolution (ALE). Adaptation of the yeast to growth on methanol over 250 generations was examined and observed a complex correlation among carbon source, cell growth and RPP. Increased specific growth rates on rich and minimal growth media was studied at the level of both population and single clone. Selected clones displayed strain-dependent variations for the yield of PAOX1-based recombinant protein expression, one showing up to 2-fold increase in terms product titer.

From a bioprocess engineering perspective, process variability often results in issues arising from changes in critical process parameters (CPPs), key parameters of interest (KPIs), or critical material attributes (CMAs), all of which in turn affect critical quality attributes (CQAs). CPPs can change throughout a culture and require using appropriate control strategies to reduce process variability. Advances in process analytical technology (PAT) and quality by design (QbD) approaches have substantially reduced times for process development. According to Hernandez (2015), in the context of transition to continuous bioprocesses it is essential to adapt these methodologies from batch to continuous cultures.

It has been stated that continuous bioprocesses require real-time monitoring of process variability in order to identify eventual deviations and to ensure consistent performance (Rajamanickam et al., 2018). Variability in KPIs (e.g., cell growth, yields, production rates) is especially important because it has a direct impact on process performance and product quality. Thus, continuous bioprocesses require real-time monitoring with standard sensors for direct measurements, or soft sensors that allow the indirect determination of parameters ensuring a high bioprocess efficiency. Recent advances in the monitoring of various cell factories, including soft-sensors, have been reviewed by several authors (Valero and López-Santín, 2017; Veloso and Ferreira, 2017; Randek and Mandenius, 2018). Nevertheless, most of the reported monitoring applications for P. pastoris have been described for batch and fed-batch operations. Besides the common sensors used for the monitoring and control of culture conditions and gas analysis, just scarce applications have been reported for continuous mode (Jungo et al., 2007a; Fazenda et al., 2013). In this scenario, further implementing PAT and QbD in P. pastoris continuous cultures has been deemed essential for industrial processes.

How Far Is the Implementation of Pichia pastoris Continuous Manufacturing Processes?

Several RPP industrial processes are currently performed with P. pastoris. Including both industrial enzymes and biopharmaceuticals, the www.pichia.com website provides a list of products manufactured with Pichia which are on the market of late stage development. However, according to the open literature, there are no reported in detail continuous biomanufacturing processes implemented with P. pastoris. Nevertheless, taking into consideration the state of the art discussed in this section, some long terms continuous examples described in the literature could eventually become interesting candidates for continuous manufacturing with P. pastoris.

A chemostat process producing recombinant hepatitis B small surface antigen (rHBsAg) was maintained working for 2 weeks reaching similar levels of product titer than at the end of a fed-batch culture. Specifically, QV and qP were, respectively, about 1.5 and 1.3 times higher, than in fed-batch mode. Interestingly, no contamination issues or/and genome instability were detected after those 2 weeks of continuous operation (Rahimi et al., 2019). In another study, the performance of continuous cultures designed as a combination of turbidostat/chemostat modes at constant cell concentration was evaluated (Wang et al., 2012). As a relevant outcome, it was reported that feeding the system with methanol resulted in high recombinant polygalacturonate lyase PGL expression and a substantial performance improvement relative to conventional fed-batch cultures. Moreover, a chemostat producing lipase B from Candida antarctica (CalB) was running 6 weeks at μ = 0.14 h−1. In this case, considering the unproductive time spent in setting up, draining out, cleaning and reassembling in fed-batch operation, the overall CalB production was 5.8 times greater than the fed-batch process (de Macedo Robert et al., 2019).

Finally, a summary including the main items required to address toward the industrial implementation of continuous cultivation with the cell factory P. pastoris is presented in Figure 3.

Figure 3.

Figure 3

Mean features in the industrial implementation of Pichia pastoris continuous cultivation.

Conclusions

The yeast P. pastoris is considered an outstanding cell factory alternative for its industrial use in production processes of both metabolites and recombinant proteins. Despite the excellent features of this host, in general, most of the bioprocesses based on fermentation technology are considered still far from achieving the maturity of other industries. In this sense, the present trends toward their optimization are provided by two complementary approaches: Strain development and bioprocess engineering. In order to achieve relevant progresses in the long road to bioprocess optimization it is essential to acquire robust and reliable knowledge of the system used. This knowledge is considered with the objective to be able to design and implement rational developments from any of the both approaches mentioned. In this context, continuous cultivation emerges as an excellent tool to accurately characterize the performance of the cell factory in terms of physiological and production parameters. Furthermore, the steady state conditions achieved during the continuous cultures and the high degree of cell population homogeneity makes this operational mode, an excellent tool toward the development of a wide range of systems biology studies including transcriptomics, proteomics, metabolomics and other cutting edge “-omics” studies.

In Figure 4 is summarized how continuous cultivation can be used as a tool toward the rational development of bioprocesses with P. pastoris. It illustrates the different approaches that, based on the results obtained in continuous cultivation (chemostat), allow to achieve rational improvements at both strain and bioprocess engineering level.

Figure 4.

Figure 4

Use of continuous cultivation as a tool toward the rational bioprocess development with Pichia pastoris cell factory by combining strain and bioprocess engineering.

Besides, the current trends of industrial biotechnology is promoting the transition from batch/fed-batch-based processes toward the continuous biomanufacturing due to the numerous advantages that present this operation mode in terms of ensuring a robust and very high product quality as well as, among others, to reduce running costs and minimizing equipment requirements. The potential implementation of biomanufacturing processes with P. pastoris has the most relevant challenges with the identification of efficient and methanol-free alternative promoters, the integration of upstream and downstream, reaching short process development times with minimal risks on quality/regulatory requirements through PAT and QbD approaches and, finally, to evaluate the impact of long-term continuous operation on genetic stability and cell physiology.

Author Contributions

MN-T and XG-O contributed writing the Abstract and the Introduction sections. MN-T and JA wrote the section: Continuous cultivations provide an excellent tool for systems biology research. JM-S and FV wrote the section: Bioprocess characterization with chemostat cultures. XG-O, JM-S, and FV wrote the section: Is continuous cultivation a real alternative for its use in industrial Pichia pastoris processes? XG-O, JM-S, and FV wrote the Conclusions section. All authors read, reviewed, and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

MN-T acknowledges award by the National Council of Science Technology and Technological Innovation (CONCYTEC) through its executing unit and the National Fund for Scientific, Technological and Technological Innovation Development (FONDECYT).

Footnotes

Funding. This work was funded by MINECO and FEDER under Project CTQ2016-74959-R. The authors' group is member 2017-SGR-1462 and the Reference Network in Biotechnology (XRB) of Generalitat de Catalunya.

References

  1. Adamberg K., Valgepea K., Vilu R. (2015). Advanced continuous cultivation methods for systems microbiology. Microbiology 161, 1707–1719. 10.1099/mic.0.000146 [DOI] [PubMed] [Google Scholar]
  2. Adelantado N., Tarazona P., Grillitsch K., García-Ortega X., Monforte S., Valero F., et al. (2017). The effect of hypoxia on the lipidome of recombinant Pichia pastoris. Microb. Cell Fact. 16:86. 10.1186/s12934-017-0699-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ahmad M., Hirz M., Pichler H., Schwab H. (2014). Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl. Microbiol. Biotechnol. 98, 5301–5317. 10.1007/s00253-014-5732-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arnau C., Casas C., Valero F. (2011). The effect of glycerol mixed substrate on the heterologous production of a Rhizopus oryzae lipase in Pichia pastoris system. Biochem. Eng. J. 57, 30–37. 10.1016/j.bej.2011.08.004 [DOI] [PubMed] [Google Scholar]
  5. Arnau C., Ramon R., Casas C., Valero F. (2010). Optimization of the heterologous production of a Rhizopus oryzae lipase in Pichia pastoris system using mixed substrates on controlled fed-batch bioprocess. Enzyme Microb. Technol. 46, 494–500. 10.1016/j.enzmictec.2010.01.005 [DOI] [PubMed] [Google Scholar]
  6. Arvas M., Pakula T., Smit B., Rautio J., Koivistoinen H., Jouhten P., et al. (2011). Correlation of gene expression and protein production rate - a system wide study. BMC Genomics 12:616. 10.1186/1471-2164-12-616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ata Ö., Prielhofer R., Gasser B., Mattanovich D., Çalik P. (2017). Transcriptional engineering of the glyceraldehyde-3-phosphate dehydrogenase promoter for improved heterologous protein production in Pichia pastoris. Biotechnol. Bioeng. 114, 2319–2327. 10.1002/bit.26363 [DOI] [PubMed] [Google Scholar]
  8. Ata Ö., Rebnegger C., Tatto N. E., Valli M., Mairinger T., Hann S., et al. (2018). A single Gal4-like transcription factor activates the Crabtree effect in Komagataella phaffii. Nat. Commun. 9:4911. 10.1038/s41467-018-07430-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Baghban R., Farajnia S., Rajabibazl M., Ghasemi Y., Mafi A., Hoseinpoor R., et al. (2019). Yeast expression systems: overview and recent advances. Mol. Biotechnol. 61, 365–384. 10.1007/s12033-019-00164-8 [DOI] [PubMed] [Google Scholar]
  10. Barrigón J. M., Valero F., Montesinos J. L. (2015). A macrokinetic model-based comparative meta-analysis of recombinant protein production by Pichia pastoris under AOX1 promoter. Biotechnol. Bioeng. 112, 1132–1145. 10.1002/bit.25518 [DOI] [PubMed] [Google Scholar]
  11. Baumann K., Carnicer M., Dragosits M., Graf A. B., Stadlmann J., Jouhten P., et al. (2010). A multi-level study of recombinant Pichia pastoris in different oxygen conditions. BMC Syst. Biol. 4:141. 10.1186/1752-0509-4-141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Baumann K., Dato L., Graf A. B., Frascotti G., Dragosits M., Porro D., et al. (2011). The impact of oxygen on the transcriptome of recombinant S. cerevisiae and P. pastoris- a comparative analysis. BMC Genomics 12:218. 10.1186/1471-2164-12-218 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Baumann K., Maurer M., Dragosits M., Cos O., Ferrer P., Mattanovich D. (2008). Hypoxic fed-batch cultivation of Pichia pastoris increases specific and volumetric productivity of recombinant proteins. Biotechnol. Bioeng. 100, 177–183. 10.1002/bit.21763 [DOI] [PubMed] [Google Scholar]
  14. Berrios J., Flores M.-O., Díaz-Barrera A., Altamirano C., Martínez I., Cabrera Z. (2017). A comparative study of glycerol and sorbitol as co-substrates in methanol-induced cultures of Pichia pastoris: temperature effect and scale-up simulation. J. Ind. Microbiol. Biotechnol. 44, 407–411. 10.1007/s10295-016-1895-7 [DOI] [PubMed] [Google Scholar]
  15. Boze H., Laborde C., Chemardin P., Richard P., Venturin C., Combarnous Y., et al. (2001). High-level secretory production of recombinant porcine follicle-stimulating hormone by Pichia pastoris. Process Biochem. 36, 907–913. 10.1016/S0032-9592(00)00296-X [DOI] [Google Scholar]
  16. Brejning J., Arneborg N., Jespersen L. (2005). Identification of genes and proteins induced during the lag and early exponential phase of lager brewing yeasts. J. Appl. Microbiol. 98, 261–271. 10.1111/j.1365-2672.2004.02472.x [DOI] [PubMed] [Google Scholar]
  17. Buchetics M., Dragosits M., Maurer M., Rebnegger C., Porro D., Sauer M., et al. (2011). Reverse engineering of protein secretion by uncoupling of cell cycle phases from growth. Biotechnol. Bioeng. 108, 2403–2412. 10.1002/bit.23198 [DOI] [PubMed] [Google Scholar]
  18. Bull A. T. (2010). The renaissance of continuous culture in the post-genomics age. J. Ind. Microbiol. Biotechnol. 37, 993–1021. 10.1007/s10295-010-0816-4 [DOI] [PubMed] [Google Scholar]
  19. Çalik P., Ata Ö., Güneş H., Massahi A., Boy E., Keskin A., et al. (2015). Recombinant protein production in Pichia pastoris under glyceraldehyde-3-phosphate dehydrogenase promoter: from carbon source metabolism to bioreactor operation parameters. Biochem. Eng. J. 95, 20–36. 10.1016/j.bej.2014.12.003 [DOI] [Google Scholar]
  20. Cámara E., Landes N., Albiol J., Gasser B., Mattanovich D., Ferrer P. (2017). Increased dosage of AOX1 promoter-regulated expression cassettes leads to transcription attenuation of the methanol metabolism in Pichia pastoris. Sci. Rep. 7:44302. 10.1038/srep44302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cámara E., Monforte S., Albiol J., Ferrer P. (2019). Deregulation of methanol metabolism reverts transcriptional limitations of recombinant Pichia pastoris (Komagataella spp) with multiple expression cassettes under control of the AOX1 promoter. Biotechnol. Bioeng. 116, 1710–1720. 10.1002/bit.26947 [DOI] [PubMed] [Google Scholar]
  22. Canales C., Altamirano C., Berrios J. (2015). Effect of dilution rate and methanol-glycerol mixed feeding on heterologous Rhizopus oryzae lipase production with Pichia pastoris Mut + phenotype in continuous culture. Biotechnol. Prog. 31, 707–714. 10.1002/btpr.2069 [DOI] [PubMed] [Google Scholar]
  23. Cankorur-Cetinkaya A., Narraidoo N., Kasavi C., Slater N. K. H., Archer D. B., Oliver S. G. (2018). Process development for the continuous production of heterologous proteins by the industrial yeast, Komagataella phaffii. Biotechnol. Bioeng. 115, 2962–2973. 10.1002/bit.26846 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Carnicer M., ten Pierick A., van Dam J., Heijnen J. J., Albiol J., van Gulik W., et al. (2012). Quantitative metabolomics analysis of amino acid metabolism in recombinant Pichia pastoris under different oxygen availability conditions. Microb. Cell Fact. 11:83. 10.1186/1475-2859-11-83 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Çelik E., Çalik P. (2012). Production of recombinant proteins by yeast cells. Biotechnol. Adv. 30, 1108–1118. 10.1016/j.biotechadv.2011.09.011 [DOI] [PubMed] [Google Scholar]
  26. Chung B. K., Selvarasu S., Andrea C., Ryu J., Lee H., Ahn J., et al. (2010). Genome-scale metabolic reconstruction and in silico analysis of methylotrophic yeast Pichia pastoris for strain improvement. Microb. Cell Fact. 9:50. 10.1186/1475-2859-9-50 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Cooney C. L. (1979). Continuous culture of microorganisms: an overview and perspective. Ann. N.Y. Acad. Sci. 326, 295–314. 10.1111/j.1749-6632.1979.tb14170.x [DOI] [Google Scholar]
  28. Cos O., Ramón R., Montesinos J. L., Valero F. (2006). Operational strategies, monitoring and control of heterologous protein production in the methylotrophic yeast Pichia pastoris under different promoters: a review. Microb. Cell Fact. 5:17. 10.1186/1475-2859-5-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Cregg J. M., Vedvick T. S., Raschke W. C. (1993). Recent advances in the expression of foreign genes in Pichia pastoris. Nat. Biotechnol. 11, 905–910. 10.1038/nbt0893-905 [DOI] [PubMed] [Google Scholar]
  30. Croughan M. S., Konstantinov K. B., Cooney C. (2015). The future of industrial bioprocessing: batch or continuous? Biotechnol. Bioeng. 112, 648–651. 10.1002/bit.25529 [DOI] [PubMed] [Google Scholar]
  31. Curvers S., Linnemann J., Klauser T., Wandrey C., Takors R. (2002). Recombinant protein production with Pichia pastoris in continuous fermentation – kinetic analysis of growth and product formation. Eng. Life Sci. 2:229 [DOI] [Google Scholar]
  32. D'Anjou M. C., Daugulis A. J. (2001). A rational approach to improving productivity in recombinant Pichia pastoris fermentation. Biotechnol. Bioeng. 72, 1–11. [DOI] [PubMed] [Google Scholar]
  33. de Macedo Robert J., Garcia-Ortega X., Montesinos-Seguí J. L., Guimaraes Freire D. M., Valero F. (2019). Continuous operation, a realistic alternative to fed-batch fermentation for the production of recombinant lipase B from Candida antarctica under the constitutive promoter PGK in Pichia pastoris. Biochem. Eng. J. 147, 39–47. 10.1016/j.bej.2019.03.027 [DOI] [Google Scholar]
  34. Delic M., Valli M., Graf A. B., Pfeffer M., Mattanovich D., Gasser B. (2013). The secretory pathway: exploring yeast diversity. FEMS Microbiol. Rev. 37, 872–914. 10.1111/1574-6976.12020 [DOI] [PubMed] [Google Scholar]
  35. Dragosits M., Frascotti G., Bernard-Granger L., Vázquez F., Giuliani M., Baumann K., et al. (2011). Influence of growth temperature on the production of antibody Fab fragments in different microbes: a host comparative analysis. Biotechnol. Prog. 27, 38–46. 10.1002/btpr.524 [DOI] [PubMed] [Google Scholar]
  36. Dragosits M., Stadlmann J., Albiol J., Baumann K., Maurer M., Gasser B., et al. (2009). The effect of temperature on the proteome of recombinant Pichia pastoris. J. Proteome Res. 8, 1380–1392. 10.1021/pr8007623 [DOI] [PubMed] [Google Scholar]
  37. Dragosits M., Stadlmann J., Graf A., Gasser B., Maurer M., Sauer M., et al. (2010). The response to unfolded protein is involved in osmotolerance of Pichia pastoris. BMC Genomics 11:207. 10.1186/1471-2164-11-207 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Engstrom M. D., Pfleger B. F. (2017). Transcription control engineering and applications in synthetic biology. Synth. Syst. Biotechnol. 2, 176–191. 10.1016/j.synbio.2017.09.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ercan O., Bisschops M. M. M., Overkamp W., Jørgensen T. R., Ram A. F., Smid E. J., et al. (2015a). Physiological and transcriptional responses of different industrial microbes at near-zero specific growth rates. Appl. Environ. Microbiol. 81, 5662–5670. 10.1128/AEM.00944-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ercan O., Wels M., Smid E. J., Kleerebezem M. (2015b). Molecular and metabolic adaptations of Lactococcus lactis at near-zero growth rates. Appl. Environ. Microbiol. 81, 320–331. 10.1128/AEM.02484-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Fazenda M. L., Dias J. M., Harvey L. M., Nordon A., Edrada-Ebel R., LittleJohn D., et al. (2013). Towards better understanding of an industrial cell factory: investigating the feasibility of real-time metabolic flux analysis in Pichia pastoris. Microb. Cell Fact. 12:51. 10.1186/1475-2859-12-51 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Fernandes B. D., Mota A., Teixeira J. A., Vicente A. A. (2015). Continuous cultivation of photosynthetic microorganisms: approaches, applications and future trends. Biotechnol. Adv. 33, 1228–1245. 10.1016/j.biotechadv.2015.03.004 [DOI] [PubMed] [Google Scholar]
  43. Ferrer P., Albiol J. (2014a). “13C-based metabolic flux analysis in yeast: the Pichia pastoris case,” in Methods in Molecular Biology, ed Mapelli V. (New York, NY: Humana Press Inc., 209–232. 10.1007/978-1-4939-0563-8_13 [DOI] [PubMed] [Google Scholar]
  44. Ferrer P., Albiol J. (2014b). “13C-Based metabolic flux analysis of recombinant Pichia pastoris,” in Metabolic Flux Analysis, eds Krömer J. O., Nielsen L. K., Blank L. M. (New York, NY: Humana Press Inc., 291–313. 10.1007/978-1-4939-1170-7_17 [DOI] [PubMed] [Google Scholar]
  45. Fong S. S. (2014). Computational approaches to metabolic engineering utilizing systems biology and synthetic biology. Comput. Struct. Biotechnol. J. 11, 28–34. 10.1016/j.csbj.2014.08.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Garcia-Ortega X., Adelantado N., Ferrer P., Montesinos J. L., Valero F. (2016). A step forward to improve recombinant protein production in Pichia pastoris: from specific growth rate effect on protein secretion to carbon-starving conditions as advanced strategy. Process Biochem. 51, 681–691. 10.1016/j.procbio.2016.02.018 [DOI] [Google Scholar]
  47. García-Ortega X., Cámara E., Ferrer P., Albiol J., Montesinos-Seguí J. L., Valero F. (2019). Rational development of bioprocess engineering strategies for recombinant protein production in Pichia pastoris (Komagataella phaffi) using the methanol free GAP promoter. Where do we stand? N. Biotechnol. 53, 24–34. 10.1016/j.nbt.2019.06.002 [DOI] [PubMed] [Google Scholar]
  48. Garcia-Ortega X., Ferrer P., Montesinos J. L., Valero F. (2013). Fed-batch operational strategies for recombinant Fab production with Pichia pastoris using the constitutive GAP promoter. Biochem. Eng. J. 79, 172–181. 10.1016/j.bej.2013.07.013 [DOI] [Google Scholar]
  49. Garcia-Ortega X., Valero F., Montesinos-Seguí J. L. (2017). Physiological state as transferable operating criterion to improve recombinant protein production in Pichia pastoris through oxygen limitation. J. Chem. Technol. Biotechnol. 92, 2573–2582. 10.1002/jctb.5272 [DOI] [Google Scholar]
  50. Garrigós-Martínez J., Nieto-Taype M. A., Gasset A., Montesinos-Seguí J. L., Garcia-Ortega X., Valero F. (2019). Specific growth rate governs AOX1 gene expression, affecting the production kinetics of Pichia pastoris (Komogataella phaffii) PAOX1-driven recombinant producer strains with different target gene dosage. Microb. Cell Fact. 181:87 10.1186/s12934-019-1240-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Gasser B., Mattanovich D. (2018). A yeast for all seasons – is Pichia pastoris a suitable chassis organism for future bioproduction? FEMS Microbiol. Lett. 365:181. 10.1093/femsle/fny181 [DOI] [PubMed] [Google Scholar]
  52. Gasser B., Maurer M., Rautio J., Sauer M., Bhattacharyya A., Saloheimo M., et al. (2007). Monitoring of transcriptional regulation in Pichia pastoris under protein production conditions. BMC Genomics 8:179. 10.1186/1471-2164-8-179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Gasser B., Prielhofer R., Marx H., Maurer M., Nocon J., Steiger M., et al. (2013). Pichia pastoris: protein production host and model organism for biomedical research. Future Microbiol. 8, 191–208. 10.2217/fmb.12.133 [DOI] [PubMed] [Google Scholar]
  54. Gerritzen M. J. H., Maas R. H. W., Van Den Ijssel J., Van Keulen L., Martens D. E., Wijffels R. H., et al. (2018). High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis. Microb. Cell Fact. 17:157. 10.1186/s12934-018-1007-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Graf A., Dragosits M., Gasser B., Mattanovich D. (2009). Yeast systems biotechnology for the production of heterologous proteins. FEMS Yeast Res. 9, 335–348. 10.1111/j.1567-1364.2009.00507.x [DOI] [PubMed] [Google Scholar]
  56. Graf A., Gasser B., Dragosits M., Sauer M., Leparc G. G., Tüchler T., et al. (2008). Novel insights into the unfolded protein response using Pichia pastoris specific DNA microarrays. BMC Genomics 9:390. 10.1186/1471-2164-9-390 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Gramelsberger G. (2018). Continuous culture techniques as simulators for standard cells: Jacques Monod's, Aron Novick's and Leo Szilard's quantitative approach to microbiology. Hist. Philos. Life Sci. 40:23. 10.1007/s40656-017-0182-x [DOI] [PubMed] [Google Scholar]
  58. Gresham D., Dunham M. J. (2014). The enduring utility of continuous culturing in experimental evolution. Genomics 104, 399–405. 10.1016/j.ygeno.2014.09.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Herbert D. (1961). “A theoretical analysis of continuous culture systems,” in Continuous Culture of Microorganisms, Microbiology Group Symposium Papers, eds Henderson D. W., Hastings J. J. H., Southgate B. A., Brian P. W. (London: Society of Chemical Industry; University College, 51–53. [Google Scholar]
  60. Hernandez R. (2015). Continuous manufacturing: a changing processing paradigm. BioPharm Int. 28, 20–41. [Google Scholar]
  61. Hesketh A. R., Castrillo J. I., Sawyer T., Archer D. B., Oliver S. G. (2013). Investigating the physiological response of Pichia (Komagataella) pastoris GS115 to the heterologous expression of misfolded proteins using chemostat cultures. Appl. Microbiol. Biotechnol. 97, 9747–9762. 10.1007/s00253-013-5186-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Heyland J., Fu J., Blank L. M., Schmid A. (2010). Quantitative physiology of Pichia pastoris during glucose-limited high-cell density fed-batch cultivation for recombinant protein production. Biotechnol. Bioeng. 107, 357–368. 10.1002/bit.22836 [DOI] [PubMed] [Google Scholar]
  63. Heyland J., Fu J., Blank L. M., Schmid A. (2011). Carbon metabolism limits recombinant protein production in Pichia pastoris. Biotechnol. Bioeng. 108, 1942–1953. 10.1002/bit.23114 [DOI] [PubMed] [Google Scholar]
  64. Hoekema S., Rinzema A., Tramper J., Wijffels R. H., Janssen M. (2014). Deceleration-stats save much time during phototrophic culture optimization. Biotechnol. Bioeng. 111, 792–802. 10.1002/bit.25131 [DOI] [PubMed] [Google Scholar]
  65. Hoskisson P. A., Hobbs G. (2005). Continuous culture - making a comeback? Microbiology 151, 3153–3159. 10.1099/mic.0.27924-0 [DOI] [PubMed] [Google Scholar]
  66. Jordà J., De Jesus S. S., Peltier S., Ferrer P., Albiol J. (2014a). Metabolic flux analysis of recombinant Pichia pastoris growing on different glycerol/methanol mixtures by iterative fitting of NMR-derived 13C-labelling data from proteinogenic amino acids. N. Biotechnol. 31, 120–132. 10.1016/j.nbt.2013.06.007 [DOI] [PubMed] [Google Scholar]
  67. Jordà J., Jouhten P., Cámara E., Maaheimo H., Albiol J., Ferrer P. (2012). Metabolic flux profiling of recombinant protein secreting Pichia pastoris growing on glucose: methanol mixtures. Microb. Cell Fact. 11:57. 10.1186/1475-2859-11-57 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Jordà J., Rojas H. C., Carnicer M., Wahl A., Ferrer P., Albiol J. (2014b). Quantitative metabolomics and instationary 13C-metabolic flux analysis reveals impact of recombinant protein production on trehalose and energy metabolism in Pichia pastoris. Metabolites 4, 281–299. 10.3390/metabo4020281 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Jungo C., Marison I., von Stockar U. (2007a). Mixed feeds of glycerol and methanol can improve the performance of Pichia pastoris cultures: a quantitative study based on concentration gradients in transient continuous cultures. J. Biotechnol. 128, 824–837. 10.1016/j.jbiotec.2006.12.024 [DOI] [PubMed] [Google Scholar]
  70. Jungo C., Rérat C., Marison I. W., von Stockar U. (2006). Quantitative characterization of the regulation of the synthesis of alcohol oxidase and of the expression of recombinant avidin in a Pichia pastoris Mut+ strain. Enzyme Microb. Technol. 39, 936–944. 10.1016/j.enzmictec.2006.01.027 [DOI] [Google Scholar]
  71. Jungo C., Schenk J., Pasquier M., Marison I. W., von Stockar U. (2007c). A quantitative analysis of the benefits of mixed feeds of sorbitol and methanol for the production of recombinant avidin with Pichia pastoris. J. Biotechnol. 131, 57–66. 10.1016/j.jbiotec.2007.05.019 [DOI] [PubMed] [Google Scholar]
  72. Jungo C., Urfer J., Zocchi A., Marison I., von Stockar U. (2007b). Optimisation of culture conditions with respect to biotin requirement for the production of recombinant avidin in Pichia pastoris. J. Biotechnol. 127, 703–715. 10.1016/j.jbiotec.2006.08.001 [DOI] [PubMed] [Google Scholar]
  73. Juturu V., Wu J. C. (2018). Heterologous protein expression in Pichia pastoris: latest research progress and applications. ChemBioChem 19, 7–21. 10.1002/cbic.201700460 [DOI] [PubMed] [Google Scholar]
  74. Kasemets K., Drews M., Nisamedtinov I., Adamberg K., Paalme T. (2003). Modification of A-stat for the characterization of microorganisms. J. Microbiol. Methods 55, 187–200. 10.1016/S0167-7012(03)00143-X [DOI] [PubMed] [Google Scholar]
  75. Khasa Y. P., Khushoo A., Srivastava L., Mukherjee K. J. (2007). Kinetic studies of constitutive human granulocyte-macrophage colony stimulating factor (hGM-CSF) expression in continuous culture of Pichia pastoris. Biotechnol. Lett. 29, 1903–1908. 10.1007/s10529-007-9473-8 [DOI] [PubMed] [Google Scholar]
  76. King Z. A., Lu J., Dräger A., Miller P., Federowicz S., Lerman J. A., et al. (2016). BiGG models: a platform for integrating, standardizing and sharing genome-scale models. Nucleic Acids Res. 44, D515–D522. 10.1093/nar/gkv1049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Landes N., Gasser B., Vorauer-Uhl K., Lhota G., Mattanovich D., Maurer M. (2016). The vitamin-sensitive promoter PTHI11 enables pre-defined autonomous induction of recombinant protein production in Pichia pastoris. Biotechnol. Bioeng. 113, 2633–2643. 10.1002/bit.26041 [DOI] [PubMed] [Google Scholar]
  78. Lee J. Y., Chen H., Liu A., Alba B. M., Lim A. C. (2017). Auto-induction of Pichia pastoris AOX1 promoter for membrane protein expression. Protein Expr. Purif. 137, 7–12. 10.1016/j.pep.2017.06.006 [DOI] [PubMed] [Google Scholar]
  79. Lin X. Q., Liang S. L., Han S. Y., Zheng S. P., Ye Y. R., Lin Y. (2013). Quantitative iTRAQ LC-MS/MS proteomics reveals the cellular response to heterologous protein overexpression and the regulation of HAC1 in Pichia pastoris. J. Proteomics 91, 58–72. 10.1016/j.jprot.2013.06.031 [DOI] [PubMed] [Google Scholar]
  80. Liu Z., Hou J., Martínez J. L., Petranovic D., Nielsen J. (2013). Correlation of cell growth and heterologous protein production by Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 97, 8955–8962. 10.1007/s00253-013-4715-2 [DOI] [PubMed] [Google Scholar]
  81. Looser V., Bruhlmann B., Bumbak F., Stenger C., Costa M., Camattari A., et al. (2015). Cultivation strategies to enhance productivity of Pichia pastoris: a review. Biotechnol. Adv. 33, 1177–1193. 10.1016/j.biotechadv.2015.05.008 [DOI] [PubMed] [Google Scholar]
  82. Lu P., Vogel C., Wang R., Yao X., Marcotte E. M. (2007). Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat. Biotechnol. 25, 117–124. 10.1038/nbt1270 [DOI] [PubMed] [Google Scholar]
  83. Maccani A., Landes N., Stadlmayr G., Maresch D., Leitner C., Maurer M., et al. (2014). Pichia pastoris secretes recombinant proteins less efficiently than Chinese hamster ovary cells but allows higher space-time yields for less complex proteins. Biotechnol. J. 9, 526–537. 10.1002/biot.201300305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Massahi A., Çalik P. (2018). Naturally occurring novel promoters around pyruvate branch-point for recombinant protein production in Pichia pastoris (Komagataella phaffii): pyruvate decarboxylase- and pyruvate kinase- promoters. Biochem. Eng. J. 138, 111–120. 10.1016/j.bej.2018.07.012 [DOI] [Google Scholar]
  85. Mattanovich D., Gasser B., Hohenblum H., Sauer M. (2004). Stress in recombinant protein producing yeasts. J. Biotechnol. 113, 121–135. 10.1016/j.jbiotec.2004.04.035 [DOI] [PubMed] [Google Scholar]
  86. Maurer M., Kühleitner M., Gasser B., Mattanovich D. (2006). Versatile modeling and optimization of fed batch processes for the production of secreted heterologous proteins with Pichia pastoris. Microb. Cell Fact. 5:37. 10.1186/1475-2859-5-37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. McGeachy A. M., Meacham Z. A., Ingolia N. T. (2019). An accessible continuous-culture turbidostat for pooled analysis of complex libraries. ACS Synth. Biol. 8, 844–856. 10.1021/acssynbio.8b00529 [DOI] [PubMed] [Google Scholar]
  88. Mears L., Feldman H., Falco F. C., Bach C., Wu M., Nørregaard A., et al. (2017). “Continuous fermentation for biopharmaceuticals?,” in Continuous Manufacturing of Pharmaceuticals, eds Kleinebudde P., Khinast J., Rantanen J. (Chichester: John Wiley & Sons, Ltd, 227–246. [Google Scholar]
  89. Monod J. (1950). La technique de culture continue, theorie et applications. Ann. l'Institut Pasteur 79, 390–410. [Google Scholar]
  90. Moser J. W., Prielhofer R., Gerner S. M., Graf A. B., Wilson I. B. H., Mattanovich D., et al. (2017). Implications of evolutionary engineering for growth and recombinant protein production in methanol-based growth media in the yeast Pichia pastoris. Microb. Cell Fact. 16:49. 10.1186/s12934-017-0661-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Nahku R., Valgepea K., Lahtvee P.-J., Erm S., Abner K., Adamberg K., et al. (2010). Specific growth rate dependent transcriptome profiling of Escherichia coli K12 MG1655 in accelerostat cultures. J. Biotechnol. 145, 60–65. 10.1016/j.jbiotec.2009.10.007 [DOI] [PubMed] [Google Scholar]
  92. Nieto-Taype M. A., Garrigós-Martínez J., Sánchez-Farrando M., Valero F., Garcia-Ortega X., Montesinos-Seguí J. L. (2020). Rationale-based selection of optimal operating strategies and gene dosage impact on recombinant protein production in Komogataella phaffii (Pichia pastoris). Microb. Biotechnol. 13, 315–327. 10.1111/1751-7915.13498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Nisamedtinov I., Lindsey G. G., Karreman R., Orumets K., Koplimaa M., Kevvai K., et al. (2008). The response of the yeast Saccharomyces cerevisiae to sudden vs. gradual changes in environmental stress monitored by expression of the stress response protein Hsp12p. FEMS Yeast Res. 8, 829–838. 10.1111/j.1567-1364.2008.00391.x [DOI] [PubMed] [Google Scholar]
  94. Niu H., Jost L., Pirlot N., Sassi H., Daukandt M., Rodriguez C., et al. (2013). A quantitative study of methanol/sorbitol co-feeding process of a Pichia pastoris Mut+/pAOX1-lacZ strain. Microb. Cell Fact. 12:33. 10.1186/1475-2859-12-33 [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Nocon J., Steiger M., Mairinger T., Hohlweg J., Rußmayer H., Hann S., et al. (2016). Increasing pentose phosphate pathway flux enhances recombinant protein production in Pichia pastoris. Appl. Microbiol. Biotechnol. 100, 5955–5963. 10.1007/s00253-016-7363-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Nocon J., Steiger M. G., Pfeffer M., Sohn S. B., Kim T. Y., Maurer M., et al. (2014). Model based engineering of Pichia pastoris central metabolism enhances recombinant protein production. Metab. Eng. 24, 129–138. 10.1016/j.ymben.2014.05.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Paulová L., Hyka P., Branská B., Melzoch K., Kovar K. (2012). Use of a mixture of glucose and methanol as substrates for the production of recombinant trypsinogen in continuous cultures with Pichia pastoris Mut+. J. Biotechnol. 157, 180–188. 10.1016/j.jbiotec.2011.10.010 [DOI] [PubMed] [Google Scholar]
  98. Peebo K., Neubauer P. (2018). Application of continuous culture methods to recombinant protein production in microorganisms. Microorganisms 6:56. 10.3390/microorganisms6030056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Peña D. A., Gasser B., Zanghellini J., Steiger M. G., Mattanovich D. (2018). Metabolic engineering of Pichia pastoris. Metab. Eng. 50, 2–15. 10.1016/j.ymben.2018.04.017 [DOI] [PubMed] [Google Scholar]
  100. Periyasamy S., Govindappa N., Sreenivas S., Sastry K. (2013). Isolation, characterization and evaluation of the Pichia pastoris sorbitol dehydrogenase promoter for expression of heterologous proteins. Protein Expr. Purif. 92, 128–133. 10.1016/j.pep.2013.09.008 [DOI] [PubMed] [Google Scholar]
  101. Pfeffer M., Maurer M., Stadlmann J., Grass J., Delic M., Altmann F., et al. (2012). Intracellular interactome of secreted antibody Fab fragment in Pichia pastoris reveals its routes of secretion and degradation. Appl. Microbiol. Biotechnol. 93, 2503–2512. 10.1007/s00253-012-3933-3 [DOI] [PubMed] [Google Scholar]
  102. Ponte X., Barrigón J. M., Maurer M., Mattanovich D., Valero F., Montesinos-Seguí J. L. (2018). Towards optimal substrate feeding for heterologous protein production in Pichia pastoris (Komagataella spp) fed-batch processes under PAOX1 control: a modelling aided approach. J. Chem. Technol. Biotechnol. 93, 3208–3218. 10.1002/jctb.5677 [DOI] [Google Scholar]
  103. Ponte X., Montesinos-Seguí J. L., Valero F. (2016). Bioprocess efficiency in Rhizopus oryzae lipase production by Pichia pastoris under the control of PAOX1 is oxygen tension dependent. Process Biochem. 51, 1954–1963. 10.1016/j.procbio.2016.08.030 [DOI] [Google Scholar]
  104. Porro D., Gasser B., Fossati T., Maurer M., Branduardi P., Sauer M., et al. (2011). Production of recombinant proteins and metabolites in yeasts: when are these systems better than bacterial production systems? Appl. Microbiol. Biotechnol. 89, 939–948. 10.1007/s00253-010-3019-z [DOI] [PubMed] [Google Scholar]
  105. Potvin G., Ahmad A., Zhang Z. (2012). Bioprocess engineering aspects of heterologous protein production in Pichia pastoris: a review. Biochem. Eng. J. 64, 91–105. 10.1016/j.bej.2010.07.017 [DOI] [Google Scholar]
  106. Prielhofer R., Maurer M., Klein J., Wenger J., Kiziak C., Gasser B., et al. (2013). Induction without methanol: novel regulated promoters enable high-level expression in Pichia pastoris. Microb. Cell Fact. 12:5. 10.1186/1475-2859-12-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Prielhofer R., Reichinger M., Wagner N., Claes K., Kiziak C., Gasser B., et al. (2018). Superior protein titers in half the fermentation time: promoter and process engineering for the glucose-regulated GTH1 promoter of Pichia pastoris. Biotechnol. Bioeng. 115, 2479–2488. 10.1002/bit.26800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Puxbaum V., Mattanovich D., Gasser B. (2015). Quo vadis? The challenges of recombinant protein folding and secretion in Pichia pastoris. Appl. Microbiol. Biotechnol. 99, 2925–2938. 10.1007/s00253-015-6470-z [DOI] [PubMed] [Google Scholar]
  109. Rahimi A., Hosseini S. N., Karimi A., Aghdasinia H., Arabi Mianroodi R. (2019). Enhancing the efficiency of recombinant hepatitis B surface antigen production in Pichia pastoris by employing continuous fermentation. Biochem. Eng. J. 141, 112–119. 10.1016/j.bej.2018.10.019 [DOI] [Google Scholar]
  110. Rajamanickam V., Herwig C., Spadiut O. (2018). Data science, modeling, and advanced PAT tools enable continuous culture. Bioprocess Int. 16, 20–25. [Google Scholar]
  111. Randek J., Mandenius C.-F. (2018). On-line soft sensing in upstream bioprocessing. Crit. Rev. Biotechnol. 38, 106–121. 10.1080/07388551.2017.1312271 [DOI] [PubMed] [Google Scholar]
  112. Rathore A. S., Agarwal H., Sharma A. K., Pathak M., Muthukumar S. (2015). Continuous processing for production of biopharmaceuticals. Prep. Biochem. Biotechnol. 45, 836–849. 10.1080/10826068.2014.985834 [DOI] [PubMed] [Google Scholar]
  113. Rebnegger C., Graf A. B., Valli M., Steiger M. G., Gasser B., Maurer M., et al. (2014). in Pichia pastoris, growth rate regulates protein synthesis and secretion, mating and stress response. Biotechnol. J. 9, 511–525. 10.1002/biot.201300334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Rebnegger C., Vos T., Graf A. B., Valli M., Pronk J. T., Daran-Lapujade P., et al. (2016). Pichia pastoris exhibits high viability and a low maintenance energy requirement at near-zero specific growth rates. Appl. Environ. Microbiol. 82, 4570–4583. 10.1128/AEM.00638-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Rossignol T., Kobi D., Jacquet-Gutfreund L., Blondin B. (2009). The proteome of a wine yeast strain during fermentation, correlation with the transcriptome. J. Appl. Microbiol. 107, 47–55. 10.1111/j.1365-2672.2009.04156.x [DOI] [PubMed] [Google Scholar]
  116. Rußmayer H., Buchetics M., Gruber C., Valli M., Grillitsch K., Modarres G., et al. (2015). Systems-level organization of yeast methylotrophic lifestyle. BMC Biol. 13:80. 10.1186/s12915-015-0186-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Sanchez-Garcia L., Martín L., Mangues R., Ferrer-Miralles N., Vázquez E., Villaverde A. (2016). Recombinant pharmaceuticals from microbial cells: a 2015 update. Microb. Cell Fact. 15:33. 10.1186/s12934-016-0437-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Schwarzhans J.-P., Wibberg D., Winkler A., Luttermann T., Kalinowski J., Friehs K. (2016). Integration event induced changes in recombinant protein productivity in Pichia pastoris discovered by whole genome sequencing and derived vector optimization. Microb. Cell Fact. 15:84. 10.1186/s12934-016-0486-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Shi X., Karkut T., Chamankhah M., Alting-Mees M., Hemmingsen S. M., Hegedus D. (2003). Optimal conditions for the expression of a single-chain antibody (scFv) gene in Pichia pastoris. Protein Expr. Purif. 28, 321–330. 10.1016/S1046-5928(02)00706-4 [DOI] [PubMed] [Google Scholar]
  120. Singh R., Kumar M., Mittal A., Mehta P. K. (2017). Microbial metabolites in nutrition, healthcare and agriculture. 3 Biotech 7:15. 10.1007/s13205-016-0586-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Sinha J., Plantz B. A., Inan M., Meagher M. M. (2005). Causes of proteolytic degradation of secreted recombinant proteins produced in methylotrophic yeast Pichia pastoris: case study with recombinant ovine interferon-? Biotechnol. Bioeng. 89, 102–112. 10.1002/bit.20318 [DOI] [PubMed] [Google Scholar]
  122. Sirén N., Weegar J., Dahlbacka J., Kalkkinen N., Fagervik K., Leisola M., et al. (2006). Production of recombinant HIV-1 Nef (negative factor) protein using Pichia pastoris and a low-temperature fed-batch strategy. Biotechnol. Appl. Biochem. 44:151. 10.1042/BA20060001 [DOI] [PubMed] [Google Scholar]
  123. Sohn S. B., Graf A. B., Kim T. Y., Gasser B., Maurer M., Ferrer P., et al. (2010). Genome-scale metabolic model of methylotrophic yeast Pichia pastoris and its use for in silico analysis of heterologous protein production. Biotechnol. J. 5, 705–715. 10.1002/biot.201000078 [DOI] [PubMed] [Google Scholar]
  124. Sørensen H. P. (2010). Towards universal systems for recombinant gene expression. Microb. Cell Fact. 9:27. 10.1186/1475-2859-9-27 [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Spadiut O., Rittmann S., Dietzsch C., Herwig C. (2013). Dynamic process conditions in bioprocess development. Eng. Life Sci. 13, 88–101. 10.1002/elsc.201200026 [DOI] [Google Scholar]
  126. Sreekrishna K. (2010). “Pichia, optimization of protein expression,” in Encyclopedia of Industrial Biotechnology, ed Flickinger M. C. (Hoboken, NJ: John Wiley & Sons, Inc.), 16. [Google Scholar]
  127. Subramanian G., Erm S., Abner K., Seiman A., Adamberg K., Vilu R. (2017). “Study of cells in the steady-state growth space,” in Continuous Biomanufacturing - Innovative Technologies and Methods, ed Subramanian G. (Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, 233–258. [Google Scholar]
  128. Surribas A., Stahn R., Montesinos J. L., Enfors S.-O., Valero F., Jahic M. (2007). Production of a Rhizopus oryzae lipase from Pichia pastoris using alternative operational strategies. J. Biotechnol. 130, 291–299. 10.1016/j.jbiotec.2007.04.009 [DOI] [PubMed] [Google Scholar]
  129. Szopinska A., Morsomme P. (2010). Quantitative proteomic approaches and their application in the study of yeast stress responses. Omi. A J. Integr. Biol. 14, 639–649. 10.1089/omi.2010.0045 [DOI] [PubMed] [Google Scholar]
  130. Tang S., Potvin G., Reiche A., Zhang Z. (2010). Modeling of phytase production by cultivation of Pichia pastoris under the control of the GAP promoter. Int. J. Chem. React. Eng. 8:11 10.2202/1542-6580.2144 [DOI] [Google Scholar]
  131. Tomàs-Gamisans M., Ferrer P., Albiol J. (2018). Fine-tuning the P. pastoris iMT1026 genome-scale metabolic model for improved prediction of growth on methanol or glycerol as sole carbon sources. Microb. Biotechnol. 11, 224–237. 10.1111/1751-7915.12871 [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Tomàs-Gamisans M., Ødum A. S. R., Workman M., Ferrer P., Albiol J. (2019). Glycerol metabolism of Pichia pastoris (Komagataella spp.) characterised by 13C-based metabolic flux analysis. N. Biotechnol. 50, 52–59. 10.1016/j.nbt.2019.01.005 [DOI] [PubMed] [Google Scholar]
  133. Tomson K., Barber J., Vanatalu K. (2006). Adaptastat—a new method for optimising of bacterial growth conditions in continuous culture: interactive substrate limitation based on dissolved oxygen measurement. J. Microbiol. Methods 64, 380–390. 10.1016/j.mimet.2005.05.014 [DOI] [PubMed] [Google Scholar]
  134. Valero F., López-Santín J. (2017). “Online analysis for industrial bioprocesses: gas analysis” in Current Developments in Biotechnology and Bioengineering, eds Larroche Ch., Sanromán M. A., Du G., Pandey A. (Amsterdam: Elsevier, 649–678. 10.1016/B978-0-444-63663-8.00022-7 [DOI] [Google Scholar]
  135. van Hove B., Love A. M., Ajikumar P. K., De Mey M. (2016). “Programming biology: expanding the toolset for the engineering of transcription,” in Synthetic Biology, eds Glieder A., Kubicek Ch. P., Mattanovich D., Wiltschi B., Sauer M. (Cham: Springer International Publishing, 1–64. [Google Scholar]
  136. Vanz A. L., Lünsdorf H., Adnan A., Nimtz M., Gurramkonda C., Khanna N., et al. (2012). Physiological response of Pichia pastoris GS115 to methanol-induced high level production of the hepatitis B surface antigen: catabolic adaptation, stress responses, and autophagic processes. Microb. Cell Fact. 11:103. 10.1186/1475-2859-11-103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Vanz A. L., Nimtz M., Rinas U. (2014). Decrease of UPR- and ERAD-related proteins in Pichia pastoris during methanol-induced secretory insulin precursor production in controlled fed-batch cultures. Microb. Cell Fact. 13, 1–10. 10.1186/1475-2859-13-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Veloso A. C., Ferreira E. C. (2017). “Online analysis for industrial bioprocesses: broth analysis” in Current Developments in Biotechnology and Bioengineering, eds Larroche Ch., Sanromán M. A., Du G., Pandey A. (Amsterdam: Elsevier, 679–704. 10.1016/B978-0-444-63663-8.00023-9 [DOI] [Google Scholar]
  139. Vieira Gomes A., Souza Carmo T., Silva Carvalho L., Mendonça Bahia F., Parachin N. (2018). Comparison of yeasts as hosts for recombinant protein production. Microorganisms 6:38. 10.3390/microorganisms6020038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Vogel C., De Sousa Abreu R., Ko D., Le S.-Y., Shapiro B. A., Burns S. C., et al. (2010). Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol. Syst. Biol. 6:400. 10.1038/msb.2010.59 [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Vogl T., Gebbie L., Palfreyman R. W., Speight R. (2018a). Effect of plasmid design and type of integration event on recombinant protein expression in Pichia pastoris. Appl. Environ. Microbiol. 84, e02712–e02717. 10.1128/AEM.02712-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Vogl T., Glieder A. (2013). Regulation of Pichia pastoris promoters and its consequences for protein production. N. Biotechnol. 30, 385–404. 10.1016/j.nbt.2012.11.010 [DOI] [PubMed] [Google Scholar]
  143. Vogl T., Sturmberger L., Fauland P. C., Hyden P., Fischer J. E., Schmid C., et al. (2018b). Methanol independent induction in Pichia pastoris by simple derepressed overexpression of single transcription factors. Biotechnol. Bioeng. 115, 1037–1050. 10.1002/bit.26529 [DOI] [PubMed] [Google Scholar]
  144. Vos T., de la Torre Cortés P., van Gulik W. M., Pronk J. T., Daran-Lapujade P. (2015). Growth-rate dependency of de novo resveratrol production in chemostat cultures of an engineered Saccharomyces cerevisiae strain. Microb. Cell Fact. 14:133. 10.1186/s12934-015-0321-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Wagenen J., Van Pape M. L., Angelidaki I. (2015). Characterization of nutrient removal and microalgal biomass production on an industrial waste-stream by application of the deceleration-stat technique. Water Res. 75, 301–311. 10.1016/j.watres.2015.02.022 [DOI] [PubMed] [Google Scholar]
  146. Wagner J. M., Alper H. S. (2016). Synthetic biology and molecular genetics in non-conventional yeasts: current tools and future advances. Fungal Genet. Biol. 89, 126–136. 10.1016/j.fgb.2015.12.001 [DOI] [PubMed] [Google Scholar]
  147. Wang H., Li J., Liu L., Li X., Jia D., Du G., et al. (2012). Increased production of alkaline polygalacturonate lyase in the recombinant Pichia pastoris by controlling cell concentration during continuous culture. Bioresour. Technol. 124, 338–346. 10.1016/j.biortech.2012.08.027 [DOI] [PubMed] [Google Scholar]
  148. Wang J., Wang X., Shi L., Qi F., Zhang P., Zhang Y., et al. (2017). Methanol-independent protein expression by AOX1 promoter with trans-acting elements engineering and glucose-glycerol-shift induction in Pichia pastoris. Sci. Rep. 7:41850. 10.1038/srep41850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Weninger A., Fischer J. E., Raschmanová H., Kniely C., Vogl T., Glieder A. (2018). Expanding the CRISPR/Cas9 toolkit for Pichia pastoris with efficient donor integration and alternative resistance markers. J. Cell. Biochem. 119, 3183–3198. 10.1002/jcb.26474 [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Yamawaki S., Matsumoto T., Ohnishi Y., Kumada Y., Shiomi N., Katsuda T., et al. (2007). Production of single-chain variable fragment antibody (scFv) in fed-batch and continuous culture of Pichia pastoris by two different methanol feeding methods. J. Biosci. Bioeng. 104, 403–407. 10.1263/jbb.104.403 [DOI] [PubMed] [Google Scholar]
  151. Yang Z., Zhang Z. (2018). Engineering strategies for enhanced production of protein and bio-products in Pichia pastoris: a review. Biotechnol. Adv. 36, 182–195. 10.1016/j.biotechadv.2017.11.002 [DOI] [PubMed] [Google Scholar]
  152. Ye R., Huang M., Lu H., Qian J., Lin W., Chu J., et al. (2017). Comprehensive reconstruction and evaluation of Pichia pastoris genome-scale metabolic model that accounts for 1243 ORFs. Bioresour. Bioprocess. 4:22. 10.1186/s40643-017-0152-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Zahrl R. J., Mattanovich D., Gasser B. (2018). The impact of ERAD on recombinant protein secretion in Pichia pastoris (Syn Komagataella spp.). Microbiology 164, 453–463. 10.1099/mic.0.000630 [DOI] [PubMed] [Google Scholar]
  154. Zahrl R. J., Peña D. A., Mattanovich D., Gasser B. (2017). Systems biotechnology for protein production in Pichia pastoris. FEMS Yeast Res. 17:fox068. 10.1093/femsyr/fox068 [DOI] [PubMed] [Google Scholar]
  155. Zhang W., Sinha J., Smith L. A., Inan M., Meagher M. M. (2005). Maximization of production of secreted recombinant proteins in Pichia pastoris fed-batch fermentation. Biotechnol. Prog. 21, 386–393. 10.1021/bp049811n [DOI] [PubMed] [Google Scholar]
  156. Zhou X.-S., Zhang Y.-X. (2002). Decrease of proteolytic degradation of recombinant hirudin produced by Pichia pastoris by controlling the specific growth rate. Biotechnol. Lett. 24, 1449–1453. 10.1023/A:1019831406141 [DOI] [Google Scholar]
  157. Ziv N., Brandt N. J., Gresham D. (2013). The use of chemostats in microbial systems biology. J. Vis. Exp. 80:50168. 10.3791/50168 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Bioengineering and Biotechnology are provided here courtesy of Frontiers Media SA

RESOURCES